Introduction {#sec1-2055207619839883}
============

Physical inactivity is considered one of the biggest public health problems of the 21st century.^[@bibr1-2055207619839883]^ Failing to meet the recommended guidelines is associated with an increased risk of morbidity due to cardiovascular disease, cancer and metabolic syndrome and general mortality.^[@bibr2-2055207619839883][@bibr3-2055207619839883][@bibr4-2055207619839883][@bibr5-2055207619839883]--[@bibr6-2055207619839883]^ There is now also substantial evidence that sedentary behaviour (SB) is an independent predictor of poor health and mortality.^[@bibr7-2055207619839883][@bibr8-2055207619839883]--[@bibr9-2055207619839883]^

Interventions to increase physical activity (PA) levels and reduce SB are clearly vital. The workplace is viewed as an important setting for health promotion and disease prevention.^[@bibr10-2055207619839883]^ Around half of weekday sitting time is work-related,^[@bibr11-2055207619839883],[@bibr12-2055207619839883]^ and up to 71% of working hours in office workers are spent sedentary.^[@bibr13-2055207619839883]^ Occupational sedentary time is predicted to further increase in future with rises in automation and information technology use.^[@bibr14-2055207619839883]^ Promotion of PA in the workplace has many potential benefits, including improved health and wellbeing of employees and economic benefits for employers.^[@bibr15-2055207619839883]^

Mobile health (mHealth) technology has rapidly gained popularity in the general population. mHealth technology includes wearable PA monitors or trackers and smartphone applications (apps) designed to help people to manage their own health and wellbeing. The potential value of mHealth in health promotion lies in its widespread appeal, accessibility and ability to reach large populations at a low cost.^[@bibr16-2055207619839883]^ It also offers the potential for tailoring of interventions to the needs of individuals or specific groups.

Studies have investigated the use of mHealth to promote PA in a range of settings, including the workplace.^[@bibr16-2055207619839883]^ Whilst the results of clinical and general population studies suggest that mHealth may be a feasible and cost-effective way to promote PA,^[@bibr17-2055207619839883]^ the findings of existing reviews have been inconclusive. Some reviews have reported nonsignificant effects of mobile technology on PA levels,^[@bibr18-2055207619839883]^ and where beneficial effects are reported, effect sizes have generally been small,^[@bibr17-2055207619839883],[@bibr19-2055207619839883][@bibr20-2055207619839883]--[@bibr21-2055207619839883]^ Additional limitations of previous reviews are the inclusion of studies where mHealth devices were used as a data collection tool rather than as an intervention in their own right,^[@bibr20-2055207619839883],[@bibr22-2055207619839883]^ and a lack of a comprehensive description of interventions and study procedures.^[@bibr19-2055207619839883]^ Furthermore, with two recent exceptions,^[@bibr17-2055207619839883],[@bibr23-2055207619839883]^ few reviews of mHealth interventions have assessed both PA and SB outcomes.

Identification of behaviour change techniques (BCTs) using standardised taxonomies is important for recognition of effective and acceptable components, to allow replication and comparison of interventions, and to facilitate further development and testing of theories.^[@bibr24-2055207619839883]^ There is also evidence that including established BCTs is associated with greater intervention effectiveness.^[@bibr25-2055207619839883]^ Despite this, previous reviews have concluded that many mHealth interventions lack an explicit theoretical basis,^[@bibr19-2055207619839883],[@bibr20-2055207619839883]^ and it remains unclear which components are most effective and accepted.^[@bibr16-2055207619839883]^ Identification or coding of included BCTs, and identifying the theoretical basis of existing studies are therefore important gaps to address.

As mHealth is such a rapidly progressing field due to advances in technology, studies have increased exponentially in a short space of time. Early reviews predominantly comprised studies of text messaging (SMS) interventions, but the emergence of new technologies (e.g. tablets, commercial wearable activity monitors, and 'exergaming') means the evidence should be frequently reviewed in order to accurately reflect the current status. Furthermore, the use and effectiveness of mHealth interventions in specific population groups remains unclear.^[@bibr23-2055207619839883]^ It is important to consider setting or context in the evaluation of mHealth interventions as due to their complex nature, various components may produce different outcomes for different individuals in different settings.^[@bibr26-2055207619839883]^ Workplace mHealth interventions may differ from general interventions in terms of both intervention content and timing of effectiveness.^[@bibr27-2055207619839883]^ To the authors' knowledge, there has been no previous systematic review of mHealth technology for promoting PA and reducing SB in workplace settings. A recent review of general digital health interventions in the workplace concluded that the evaluation of smartphone apps in this context is an important 'next step' for future research.^[@bibr28-2055207619839883]^

Employee populations potentially have much to gain from mHealth interventions for PA and SB, yet little is known about the impact of this technology in a workplace context. Feasibility and acceptability are important aspects to consider but remain understudied and underreported.^[@bibr26-2055207619839883]^ This review therefore aims to provide a comprehensive synthesis of current evidence in relation to the effectiveness, feasibility and acceptability of mHealth interventions in the promotion of PA and reduction of SB in the workplace. This includes a description of intervention content in terms of common BCTs using an established behaviour change taxonomy, and a consideration of subgroup differences and the wider impact of interventions on health and related outcomes.

Methods {#sec2-2055207619839883}
=======

Protocol and registration {#sec3-2055207619839883}
-------------------------

The review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines (Additional file 1).^[@bibr29-2055207619839883]^ The protocol was registered with the University of York Centre for Reviews and Dissemination PROSPERO database (CRD42017058856).

Data sources and search strategy {#sec4-2055207619839883}
--------------------------------

Searches were conducted in the following databases: MEDLINE, SPORTDiscus, Scopus, EMBASE, PsycINFO, Web of Science and the Cochrane library (including the Cochrane Database of Systematic Reviews (CDSR), Cochrane Central Register of Controlled Trials (CENTRAL), Database of Abstracts of Reviews and Effect (DARE) and Health Technology Assessment (HTA)). Studies with a publication date between January 2007 (around the time smartphones were introduced) and February 2017 were included, with no language restriction. Full updated searches were later conducted to include studies to the end of February 2018, then to the end of December 2018. A master search strategy was developed (Additional file 2) and revised for each database (see Additional file 3 for example search strategy for MEDLINE). Both free text searching and controlled vocabulary were used, including key terms such as 'mHealth', 'smartphone', 'application or app', 'activity monitor or tracker', 'physical activity', 'sedentary', 'workplace' and 'occupation'.

In addition, relevant studies were identified via forward and backward citation searching, including reference lists of included articles and published systematic reviews. A search of grey literature, using the same key terms and for the same time period, included dissertations and theses (ProQuest Dissertations and Theses Global), 'mHealth Evidence', and the 'Fitabase' research library (studies using the Fitbit® activity tracker).

Inclusion criteria and study selection {#sec5-2055207619839883}
--------------------------------------

Both experimental (e.g. randomised controlled trials, RCTs) and quasi-experimental (e.g. pre-post uncontrolled trials) study designs were included. Studies were included if they: 1) used mHealth (including mobile phone, smartphone apps, personal digital assistants (PDAs), tablets, wearable activity monitors/trackers) as a major component of the intervention, as stated by the authors or apparent from the context of the paper, 2) included a control or comparison group (experimental studies) or pre- and post- exposure data (quasi-experimental and observational studies), 3) recruited participants in the workplace and/or the intervention was delivered in the workplace, and 4) included any measure of PA and/or SB (self-reported or objective) as a primary quantitative outcome.

Pilot and feasibility trials were included if they met the inclusion criteria. Interventions could be either standalone mHealth or multi-component (e.g. facilitated with telephone counselling). The rationale for including multi-component interventions was that many digital workplace interventions for PA and SB, as delivered in the real world, are part of multi-component health promotion programmes,^[@bibr30-2055207619839883]^ and we wanted to maximise the number of studies for inclusion and scope of the review. Interventions could be designed as an exclusive workplace or a wider lifestyle intervention (i.e. where the intervention was initiated or delivered in the workplace but also included activity outside of working hours). Studies using smartphone apps for PA or SB alone or with other behaviours (e.g. diet, weight) were included.

Exclusion criteria were studies reporting web-only interventions or traditional pedometers (i.e. not able to transmit data to a consumer interface), as these fall outside the realm of mHealth technology. Interventions involving basic text messaging (SMS) alone were excluded as these have been more extensively reviewed in the past,^[@bibr19-2055207619839883]^ and are felt to be a different type of intervention than more advanced mHealth tools such as multimedia smartphone apps and activity monitors. Studies using mobile devices for data collection only, and studies with clinical or student populations (i.e. school, college, university) were excluded. Studies reporting only qualitative data, non-human studies, review articles and editorials, and reports published only as conference abstracts or proceedings were also excluded.

All search results were imported into EndNote X7 bibliographic software (Thompson Reuters, San Francisco, CA, USA) and duplicates removed. Two independent reviewers (SAB and AJW) screened papers for eligibility by title and abstract followed by full text screening. Disagreements were resolved through discussion and consulting a third reviewer (KM).

Data extraction {#sec6-2055207619839883}
---------------

Standardised data extraction forms were completed by one reviewer (SAB) and verified by a second reviewer (AJW). Any disagreements were resolved through discussion and consulting a third reviewer (KM). The following data were captured: author; year; country; setting or workplace; study design; participants (number and characteristics); intervention description (type of mHealth technology or tool, intervention components including whether standalone mHealth or multi-component, theoretical basis, key motivational strategies or BCTs, duration and frequency); control or comparator; study aim (i.e. increase PA and/or reduce SB); primary PA/SB outcome (including method of assessment); secondary outcomes; duration of follow-up; main study results including any relevant subgroup findings; details of acceptability, engagement and attrition. Key within- and between-group quantitative findings were summarised for each study; significant effects were *P* \< 0.05.

Study quality assessment {#sec7-2055207619839883}
------------------------

Included studies were appraised using the Effective Public Health Practice Project (EPHPP) quality assessment tool for quantitative studies.^[@bibr31-2055207619839883]^ This tool was developed for health promotion interventions and was selected for its application to a wide range of study designs (e.g. RCTs, cohort trials and case-control studies). The tool has demonstrated content and construct validity and both intra- and inter-rater reliability.^[@bibr31-2055207619839883],[@bibr32-2055207619839883]^

The EPHPP quality assessment tool assesses six domains: 1) selection bias; 2) study design; 3) confounders; 4) blinding; 5) data collection methods; and 6) withdrawals and dropouts. Each study was given a rating of 'strong', 'moderate' or 'weak' for each domain; based on this, a global rating was then assigned for each study -- 'strong' (no weak ratings), 'moderate' (one weak rating) or 'weak' (two or more weak ratings). Intervention integrity (proportion of participants receiving the intended intervention), fidelity of delivery (whether studies measured consistency of intervention) and appropriateness of analysis methods were also separately considered.

Two independent raters (SAB and AJW) used the tool to assess risk of bias and study quality. KM was consulted to resolve any uncertainties.

Coding of BCTs {#sec8-2055207619839883}
--------------

Interventions in included studies were coded for BCTs using definitions provided in the 'Coventry, Aberdeen and London -- Refined' taxonomy for PA and healthy eating behaviours.^[@bibr33-2055207619839883]^ This 40-item evidence-based taxonomy was selected as it was specifically designed for PA and healthy eating behaviours, and is widely used including to characterise smartphone apps for PA and wearable activity monitors.^[@bibr34-2055207619839883],[@bibr35-2055207619839883]^ Content was coded for each intervention as a whole (i.e. mHealth and any additional components) using information from relevant results and protocol papers. Coding was completed by two independent reviewers (SAB and AJW) who were trained in Michie et al.'s Behaviour Change Taxonomy v1,^[@bibr36-2055207619839883]^ and consensus was reached through discussion.

Results {#sec9-2055207619839883}
=======

Study selection {#sec10-2055207619839883}
---------------

A flow diagram of the study selection process is shown in [Figure 1](#fig1-2055207619839883){ref-type="fig"}. A total of 2820 publications were identified in the initial searches (2815 from databases and 5 from other sources). After removal of duplicates, 1897 publication titles and abstracts were screened. The full text was obtained for 71 publications; of these, 18 publications describing 15 studies met the criteria for inclusion.^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883][@bibr40-2055207619839883][@bibr41-2055207619839883][@bibr42-2055207619839883][@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883][@bibr46-2055207619839883][@bibr47-2055207619839883][@bibr48-2055207619839883][@bibr49-2055207619839883][@bibr50-2055207619839883][@bibr51-2055207619839883][@bibr52-2055207619839883][@bibr53-2055207619839883]--[@bibr54-2055207619839883]^ An updated search to February 2018 found an additional five publications describing four studies,^[@bibr55-2055207619839883][@bibr56-2055207619839883][@bibr57-2055207619839883][@bibr58-2055207619839883]--[@bibr59-2055207619839883]^ and a second updated search to December 2018 found an additional seven publications for six studies,^[@bibr60-2055207619839883][@bibr61-2055207619839883][@bibr62-2055207619839883][@bibr63-2055207619839883][@bibr64-2055207619839883][@bibr65-2055207619839883]--[@bibr66-2055207619839883]^ resulting in a total of 30 publications (25 studies) for inclusion in the review.

![Flow diagram of study selection process.](10.1177_2055207619839883-fig1){#fig1-2055207619839883}

Study and intervention characteristics {#sec11-2055207619839883}
--------------------------------------

The characteristics of the 25 included studies are summarised in [Table 1](#table1-2055207619839883){ref-type="table"}. Eleven studies were conducted in the USA,^[@bibr42-2055207619839883][@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883]--[@bibr46-2055207619839883],[@bibr50-2055207619839883],[@bibr53-2055207619839883],[@bibr57-2055207619839883],[@bibr59-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883]^ five in Australia,^[@bibr37-2055207619839883],[@bibr38-2055207619839883],[@bibr49-2055207619839883],[@bibr55-2055207619839883],[@bibr56-2055207619839883],[@bibr61-2055207619839883],[@bibr66-2055207619839883]^ two in Canada,^[@bibr58-2055207619839883],[@bibr63-2055207619839883]^ two in the Netherlands,^[@bibr52-2055207619839883],[@bibr54-2055207619839883]^ one in Belgium,^[@bibr64-2055207619839883],[@bibr65-2055207619839883]^ Singapore,^[@bibr39-2055207619839883],[@bibr40-2055207619839883]^ Finland,^[@bibr47-2055207619839883],[@bibr48-2055207619839883]^ Norway,^[@bibr51-2055207619839883]^ and one in multiple countries.^[@bibr41-2055207619839883]^ Workplace settings included academic and academic medical institutions,^[@bibr42-2055207619839883][@bibr43-2055207619839883]--[@bibr44-2055207619839883],[@bibr50-2055207619839883],[@bibr53-2055207619839883],[@bibr57-2055207619839883],[@bibr59-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883]^ healthcare,^[@bibr63-2055207619839883],[@bibr66-2055207619839883]^ health insurance,^[@bibr45-2055207619839883],[@bibr49-2055207619839883]^ wellbeing improvement,^[@bibr46-2055207619839883]^ property and infrastructure,^[@bibr37-2055207619839883],[@bibr38-2055207619839883]^ pension insurance,^[@bibr47-2055207619839883],[@bibr48-2055207619839883]^ financial services,^[@bibr61-2055207619839883]^ road maintenance,^[@bibr51-2055207619839883]^ and haulage.^[@bibr55-2055207619839883],[@bibr56-2055207619839883]^ Six studies targeted multiple organisations.^[@bibr39-2055207619839883][@bibr40-2055207619839883]--[@bibr41-2055207619839883],[@bibr52-2055207619839883],[@bibr54-2055207619839883],[@bibr58-2055207619839883],[@bibr64-2055207619839883],[@bibr65-2055207619839883]^ Both public and private sector organisations were represented.

###### 

Characteristics of included studies.

![](10.1177_2055207619839883-table1)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author\                                                                                                               Setting/workplace                                                                                        Study design                                                                                                  Participants                                                                                                                              Type of mHealth technology/tool^a^                                              Intervention                                                                                                                                                                                        Control/comparison group(s)                                                                             Aim       Primary PA/SB outcome(s) (**OB** or **SR**)                                                                                                           Secondary outcome(s)                                                                                                                                                                   Length of follow-up
  Year\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Country                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  --------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- --------- ----------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------
  Brakenridge et al. 2016 (protocol)^37^\                                                                               International property and infrastructure group (Lendlease)                                              Cluster RCT                                                                                                   *n* = 153\                                                                                                                                Wearable activity monitor and smartphone app                                    Waist-worn 'LUMOback' activity monitor (LUMO Bodytech, USA) and associated smartphone app with organisational support.                                                                              Organisational support only -- e.g. manager support, e-mails and educational materials.                 SB        Average time per day spent sitting (work hours and overall)\                                                                                          Average time per day spent in prolonged sitting bouts (30 min or more), standing and stepping\                                                                                         12 months
  Brakenridge et al. 2016 (results)^[@bibr38-2055207619839883]^\                                                                                                                                                                                                                                                                               54% M, 46% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**OB**, activPAL3™ accelerometer)                                                                                                                    Daily steps\                                                                                                                                                                           
  Australia                                                                                                                                                                                                                                                                                                                                    Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Average time period between sitting bouts\                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                               IG: 37.6±7.8\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Job performance, job control and work satisfactionStress, physical and mental health-related QoL\                                                                                      
                                                                                                                                                                                                                                                                                                                                               CG: 40.0±8.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Activity monitor usage                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                               Office workers (at least 0.5 FTE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Finkelstein et al. 2015 (protocol and baseline data)^[@bibr39-2055207619839883]^\                                     13 organisations (various industries and government sectors)                                             RCT (4-arm)                                                                                                   *n* = 800\                                                                                                                                Wearable activity monitor (and website)                                         Waist-worn Fitbit Zip activity monitor (Fitbit, USA) and associated website.Monetary incentives:\                                                                                                   No activity monitor or incentives.\                                                                     PA        MVPA bout minutes per week\                                                                                                                           Mean daily step count\                                                                                                                                                                 12 months
  Finkelstein et al. 2016 (results)^[@bibr40-2055207619839883]^\                                                                                                                                                                                                                                                                               46% M, 54% F\                                                                                                                                                                                                             IG1 = Fitbit only\                                                                                                                                                                                  Educational booklets on PA only.                                                                                  (**OB**, ActiGraph™ GT-3x+ accelerometer)                                                                                                             % of participants meeting 70,000 weekly step goal\                                                                                                                                     
  Singapore                                                                                                                                                                                                                                                                                                                                    Age\                                                                                                                                                                                                                      IG2 = Fitbit and charity donation\                                                                                                                                                                                                                                                                                                                                                                                                                                          Weight\                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               IG1: 35.4±8.3\                                                                                                                                                                                                            IG3 = Fitbit and cash\                                                                                                                                                                                                                                                                                                                                                                                                                                                      Systolic BP\                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                               IG2: 35.5±8.6\                                                                                                                                                                                                            Educational booklets on PA.                                                                                                                                                                                                                                                                                                                                                                                                                                                 Cardiorespiratory fitness\                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                               IG3: 35.5±8.4\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Quality of life\                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                               CG: 35.6±8.6\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Weekly step count\                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                               Mostly desk-based employees (full-time)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sedentary, light, moderate and vigorous PA (min/week)\                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Participants meeting 150 min per week moderate PA\                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Participants meeting 10,000 daily step target                                                                                                                                          

  Ganesan et al. 2016^[@bibr41-2055207619839883]^\                                                                      481 employers (private and public sector organisations) in 1481 cities                                   Prospective cohort (pre- and post- uncontrolled)                                                              *n* = 69,219\                                                                                                                             Smartphone app                                                                  Non-interactive pedometer and 'Stepathlon' mobile app (also available as website).                                                                                                                  No control or comparison group                                                                          PA + SB   Daily steps\                                                                                                                                          Number of exercise days/week\                                                                                                                                                          100 days (approx.)
  64 countries (majority of participants from India (90.2%), Australia (5%), New Zealand (1.1%) and Singapore (0.6%))                                                                                                                                                                                                                          76% M, 24% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**SR**, pedometer data entered by participants)                                                                                                      Exercise duration (\<30 or ≥30 min/day)\                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sitting duration (hours/day)\                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                               36.0±8.4\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Weight in kilograms                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                               Adult employees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Gilson et al. 2016 (baseline data and smartphone use)^[@bibr55-2055207619839883]^\                                    Two large Australian haulage companies                                                                   Prospective cohort (pre- and post- uncontrolled feasibility study)                                            *n* = 44\                                                                                                                                 Wearable activity monitor and smartphone app                                    Wrist-worn Jawbone UP activity monitor (Jawbone, USA) used with associated smartphone app.\                                                                                                         No control or comparison group                                                                          PA + SB   Proportions of work time and non-work time spent physically active, sedentary and stationary + (i.e. sitting with upper limb movement or standing)\   Workday diet (fruit, vegetable, saturated fat and sugar intake)\                                                                                                                       28 weeks (approx.)
  Gilson et al. 2017 (results)^[@bibr56-2055207619839883]^ Australia                                                                                                                                                                                                                                                                           100% M, 0% F\                                                                                                                                                                                                             Monetary incentives (vouchers for attaining step goals and logging diet)                                                                                                                                                                                                                                              (**OB** -- GENEActiv™ wrist accelerometer)                                                                                                            Engagement with the intervention\                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                               Age 47.0±10.1\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Qualitative outcomes (interviews) --driver and depot manager experiences; perceived impact of the intervention; barriers to PA                                                         
                                                                                                                                                                                                                                                                                                                                               Truck drivers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Gremaud et al. 2018^[@bibr60-2055207619839883]^ USA                                                                   Academic organisation (university)                                                                       RCT                                                                                                           *n* = 146\                                                                                                                                Wearable activity monitor and smartphone app (web-based)                        Waist-worn Fitbit Zip activity monitor (Fitbit, USA) used with 'MapTrek' app for gamified walking.                                                                                                  Activity monitor only                                                                                   PA + SB   Daily steps\                                                                                                                                          Bouts of sedentary behaviour (consecutive minutes with 0 steps)                                                                                                                        10 weeks
                                                                                                                                                                                                                                                                                                                                               25% M, 75% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Daily active minutes (minutes with ≥100 steps/min)\                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            (**OB** -- data from Fitbit)                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                               IG: 40.6±11.7\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               CG: 40.3±11.1\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               Sedentary office workers (full-time)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Jones 2016^[@bibr42-2055207619839883]^ USA                                                                            Academic medical centre (Wake Forest Baptist Health)                                                     Prospective cluster trial (with asynchronous control group)                                                   *n* = 47\                                                                                                                                 Wearable activity monitor (and computer software)                               Clip-on Fitbit One activity monitor (Fitbit, USA) and associated software, with wellness education.\                                                                                                Usual treatment (blinded activity monitors for data collection)                                         PA + SB   Daily steps\                                                                                                                                          Life satisfaction\                                                                                                                                                                     6 months
                                                                                                                                                                                                                                                                                                                                               18% M, 82% F\                                                                                                                                                                                                             IG1 = Fitbit only\                                                                                                                                                                                                                                                                                                    Daily sedentary time\                                                                                                                                 Anxiety (state and trait)\                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                      IG2 = Fitbit and shared active workstations                                                                                                                                                                                                                                                                           BMI\                                                                                                                                                  Health-related quality of life\                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                               Overall mean = 50.8, range 25 to 74 years (SD not reported)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    (**OB** -- steps and sedentary time from Fitbit. BMI assessed objectively)                                                                            Self-reported sleep patterns                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                               Sedentary employees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Koyle 2013^[@bibr43-2055207619839883]^ USA                                                                            Academic medical centre (University of Utah Health Care)                                                 RCT                                                                                                           *n* = 73\                                                                                                                                 Smartphone app with integrated accelerometer (and motivational text messages)   'Adidas miCoach' smartphone app to track walking exercise.\                                                                                                                                         Smartphone app and educational materials (same as intervention group). No motivational text messages.   PA        Walking distance and duration\                                                                                                                        Walking for exercise self-efficacy beliefs\                                                                                                                                            6 weeks
                                                                                                                                                                                                                                                                                                                                               0% M, 100% F\                                                                                                                                                                                                             Educational materials on PA.\                                                                                                                                                                                                                                                                                         (**OB** -- smartphone app-integrated accelerometer for collection of PA data)                                                                         Likeliness of participating in other forms of PA beyond walking\                                                                                                                       
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                      Tailored motivational text messages.                                                                                                                                                                                                                                                                                                                                                                                                                                        Height and weight (BMI)\                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               46.5±7.6\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Resting pulse rate\                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                               Physically inactive employees (\<150 min exercise per week)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Systolic BP\                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Qualitative experiences of the intervention (survey)                                                                                                                                   

  Losina et al. 2017^[@bibr57-2055207619839883]^ USA                                                                    Academic medical centre (Brigham and Women's Hospital, Boston, Massachusetts)                            Prospective cohort (pre- and post- uncontrolled feasibility study)                                            *n* = 292\                                                                                                                                Wearable activity monitor (linked with websites)                                Wrist-worn Fitbit Flex activity monitor (Fitbit, USA) used with Fitbit website and study website for monitoring PA and progress.\                                                                   No control or comparison group                                                                          PA        Average weekly minutes of MVPA\                                                                                                                       Fitbit wear adherence (number of weeks wearing Fitbit for ≥10 h/day and ≥4 days/week)\                                                                                                 26 weeks (including two pre-intervention weeks)
                                                                                                                                                                                                                                                                                                                                               17% M, 83% F\                                                                                                                                                                                                             Monetary incentives (individual and team) for meeting PA goals.                                                                                                                                                                                                                                                       Proportion of participants meeting weekly MVPA goals and CDC PA guidelines\                                                                           Participant satisfaction with programme                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               Age 38±11\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      (**OB** -- step data from Fitbit converted to weekly minutes of MVPA)                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                               Sedentary, non-clinician hospital employees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Neil-Sztramko et al. 2017^[@bibr58-2055207619839883]^ Canada                                                          Multiple workplaces in Greater Vancouver (nursing, emergency services, casinos and airport)              Prospective cohort (pre- and post- uncontrolled feasibility study)                                            *n* = 20\                                                                                                                                 Wearable activity monitor and smartphone app (or website)                       Wrist-worn Fitbit Flex activity monitor (Fitbit, USA) used with Fitbit app and/or website.\                                                                                                         No control or comparison group                                                                          PA        MVPA (total min/week and min/week bouts ≥10 mins)\                                                                                                    Daily steps\                                                                                                                                                                           12 weeks
                                                                                                                                                                                                                                                                                                                                               0% M, 100% F\                                                                                                                                                                                                             Distance-based behavioural counselling (telephone/online)                                                                                                                                                                                                                                                             (**OB** - ActiGraph™ GT-3x+ accelerometer)                                                                                                            Sedentary time (min/week bouts ≥10 mins)\                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               Age 42.2±8.6\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Self-reported PA and sedentary timeBody weight and BMI\                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               Female shift workers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Physical and mental health-related QoL\                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sleep quantity and quality\                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Feasibility outcomes: demand (reach and recruitment), implementation (delivery and resources) and acceptability (attrition and adherence to intervention, participant satisfaction).   

  Olsen et al. 2018^[@bibr61-2055207619839883]^ Australia                                                               Financial services organisation (Brisbane)                                                               Prospective cohort (pre- and post- uncontrolled pilot)                                                        *n* = 49\                                                                                                                                 Wearable activity monitor and smartphone app                                    Wrist-worn Jawbone activity monitor (Jawbone, USA) used with associated app.\                                                                                                                       No control or comparison group                                                                          SB        Sitting time (including overall and occupational, min/day)\                                                                                           Light PA and MVPA (min/day, accelerometer-assessed)\                                                                                                                                   6 weeks
                                                                                                                                                                                                                                                                                                                                               31% M, 69% F^b^\                                                                                                                                                                                                          Group-based action planning session.\                                                                                                                                                                                                                                                                                 (**OB** - ActiGraph™ GT-3x+ accelerometer, also self-reported sitting time assessed using adapted version of Workforce Sitting Questionnaire)         Self-reported PA (min/week, assessed using adapted version of Active Australia survey)\                                                                                                
                                                                                                                                                                                                                                                                                                                                               Age 39.5±8.7\                                                                                                                                                                                                             Weekly e-mail reminders and resources.\                                                                                                                                                                                                                                                                                                                                                                                                                                     Acceptability of the intervention (survey-assessed)                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                               Flexible workers (e.g. work from home 1 day/week)                                                                                                                                                                         Healthy living seminar                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Patel et al. 2016^[@bibr44-2055207619839883]^ (study 1) USA                                                           Academic organisation (University of Pennsylvania)                                                       RCT (4-arm)                                                                                                   *n* = 281 (279 completed baseline assessment)\                                                                                            Smartphone app with integrated accelerometer                                    'Moves' smartphone app (Proto Geo Oy, Finland) for step tracking.\                                                                                                                                  Smartphone app and daily feedback (as intervention group). No financial incentives.                     PA        Proportion of participant-days 7000 step goal achieved during intervention\                                                                           Proportion of participant-days 7000 step goal achieved during follow-up\                                                                                                               26 weeks
                                                                                                                                                                                                                                                                                                                                               22% M, 78% F\                                                                                                                                                                                                             Daily feedback on steps.\                                                                                                                                                                                                                                                                                             (**OB** -- smartphone app-integrated accelerometer)                                                                                                   Daily steps -- intervention and follow-up                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                      Monetary incentives:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               IG1: 37.1±10.9\                                                                                                                                                                                                           IG1 = gain incentive\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               IG2: 40.3±11.2\                                                                                                                                                                                                           IG2 = lottery incentive\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                               IG3: 41.9±11.6\                                                                                                                                                                                                           IG3 = loss incentive                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               CG: 39.4±12.2\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               Overweight and obese employees (BMI ≥27 kg/m^2^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Patel et al. 2016^[@bibr45-2055207619839883]^ (study 2) USA                                                           Health insurance organisation (Independence Blue Cross)                                                  RCT (4-arm)                                                                                                   *n* = 304\                                                                                                                                Smartphone app with integrated accelerometer                                    'Moves' smartphone app (Proto Geo Oy, Finland) for step tracking.\                                                                                                                                  Smartphone app and daily feedback (as intervention group). No financial incentives.                     PA        Proportion of participant-days 7000 step goal achieved during intervention\                                                                           Proportion of participant-days 7000 step goal achieved during follow-up\                                                                                                               26 weeks
                                                                                                                                                                                                                                                                                                                                               23% M, 77% F\                                                                                                                                                                                                             Daily feedback on steps.\                                                                                                                                                                                                                                                                                             (**OB** -- smartphone app-integrated accelerometer)                                                                                                   Daily steps -- intervention and follow-up                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                      Monetary incentives:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               IG1: 39.3±10.2\                                                                                                                                                                                                           IG1 = individual\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                               IG2: 38.7±10.2\                                                                                                                                                                                                           IG2 = team\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                               IG3:41.2±10.8\                                                                                                                                                                                                            IG3 = combined                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                               CG: 43.2±10.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               Mostly sedentary employees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Patel et al. 2018^[@bibr62-2055207619839883]^ USA                                                                     Academic organisation (University of Pennsylvania)                                                       RCT (4 arm)                                                                                                   *n* = 209\                                                                                                                                Smartphone app with integrated accelerometer                                    'Moves' smartphone app (Proto Geo Oy, Finland) for step tracking.\                                                                                                                                  Smartphone app and daily feedback (as intervention group). No financial incentives.                     PA        Proportion of participant-days 7000 step goal achieved during intervention\                                                                           Proportion of participant-days 7000 step goal achieved during follow-up\                                                                                                               26 weeks
                                                                                                                                                                                                                                                                                                                                               23% M, 77% F\                                                                                                                                                                                                             Daily feedback on steps.\                                                                                                                                                                                                                                                                                             (**OB** -- smartphone app-integrated accelerometer)                                                                                                   Daily steps -- intervention and follow-up                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                      Monetary incentives:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               IG1: 41.2±11.1\                                                                                                                                                                                                           IG1 = higher frequency, smaller reward lottery\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                               IG2: 40.6±10.5\                                                                                                                                                                                                           IG2 = jackpot lottery\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                               IG3: 42.9±10.3\                                                                                                                                                                                                           IG3 = combined lottery                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                               CG: 40.0±11.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               Overweight and obese employees (BMI ≥27 kg/m^2^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Poirier et al. 2016^[@bibr46-2055207619839883]^ USA                                                                   Wellbeing improvement company (Healthways Inc)                                                           RCT                                                                                                           *n* = 265\                                                                                                                                Wearable activity monitor (linked with website, and optional text messages)     Hip- or shoe-worn Pebble+ activity monitor (Fitlinxx Inc, USA) used with 'Walkadoo' internet-based program. Electronic messaging.                                                                   One week of blinded activity monitor wear, then instructed to maintain their usual activity routine.    PA        Daily steps\                                                                                                                                          Proportion of participants increasing steps by 1000/day\                                                                                                                               6 weeks
                                                                                                                                                                                                                                                                                                                                               34% M, 66% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**OB** -- activity monitor and website)                                                                                                              Engagement with intervention -- wear time, e-mail opening and website visits                                                                                                           
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                               IG: 40.3±11.4\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               CG: 39.6±12.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               Headquarter-based employees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Reijonsaari et al. 2009 (protocol)^[@bibr47-2055207619839883]^\                                                       Insurance company                                                                                        RCT                                                                                                           *n* = 544 (521 included in analysis)\                                                                                                     Wearable activity monitor (linked with website)                                 Belt-worn 'AM 200' activity monitor/ accelerometer (PAM BV, Netherlands) used with associated website.\                                                                                             Educational materials on PA. Written results of fitness tests.                                          PA        Weekly MET-minutes of total activity\                                                                                                                 Body weight (kg)\                                                                                                                                                                      12 months
  Reijonsaari et al. 2012 (results)^[@bibr48-2055207619839883]^ Finland                                                                                                                                                                                                                                                                        36% M, 64% F\                                                                                                                                                                                                             Educational materials on PA. Written results of fitness tests.\                                                                                                                                                                                                                                                       Work productivity\                                                                                                                                    Waist circumference (cm)\                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                      Distance counselling (telephone/online)                                                                                                                                                                                                                                                                               Sickness absence\                                                                                                                                     Body fat percentage\                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               IG: 43±10.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    (**SR** -- MET-minutes from IPAQ, productivity from QQ instrument but objective sickness absence data)                                                Systolic and diastolic BP (mmHg)\                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                               CG: 44±10.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Aerobic fitness (maximal oxygen uptake, VO~2~ max, ml/kg/min)                                                                                                                          
                                                                                                                                                                                                                                                                                                                                               Mainly clerical employees (working ≥8 h per week)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Reed et al. 2018^[@bibr63-2055207619839883]^ Canada                                                                   Tertiary care cardiovascular institute (University of Ottawa Heart Institute)                            Parallel-group randomised trial (3-arm)                                                                       *n* = 76\                                                                                                                                 Wearable activity monitor (linked with website)                                 Ankle-worn Tractivity® activity monitor (Tractivity®, Vancouver, BC) linked with website for monitoring PA and taking part in challenges:\                                                          No control or comparison group                                                                          PA        MVPA (weekly minutes in bouts ≥10 mins)\                                                                                                              Body mass (kg)\                                                                                                                                                                        6 weeks
                                                                                                                                                                                                                                                                                                                                               3% M, 97% F\                                                                                                                                                                                                              IG1 = individual challenge\                                                                                                                                                                                                                                                                                           Daily steps\                                                                                                                                          BMI\                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               Age 46.3±10.9\                                                                                                                                                                                                            IG2 = friend challenge\                                                                                                                                                                                                                                                                                               (**OB** -- data from Tractivity® activity monitor)                                                                                                    Waist circumference\                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               Nurses                                                                                                                                                                                                                    IG3 = team challenge                                                                                                                                                                                                                                                                                                                                                                                                                                                        Body fat %\                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Resting systolic BP                                                                                                                                                                    

  Rowe-Roberts et al. 2014^[@bibr49-2055207619839883]^ Australia                                                        Private healthcare and insurance company (Australian Unity group)                                        Prospective cohort (uncontrolled pilot)                                                                       *n* = 212\                                                                                                                                Wearable activity monitor                                                       Waist-worn Fitbit Ultra activity monitor (Fitbit, USA)                                                                                                                                              No control or comparison group                                                                          PA        Daily steps\                                                                                                                                          AUSDRISK (Australian Type 2 Diabetes Risk Assessment Tool) score\                                                                                                                      7 months
                                                                                                                                                                                                                                                                                                                                               38% M, 62% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**OB** -- step data from Fitbit)                                                                                                                     Engagement with intervention (activity monitor wear)\                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Qualitative outcomes (survey and focus groups) -- experiences, engagement and activity, preferred motivational strategies                                                              
                                                                                                                                                                                                                                                                                                                                               42% under 35\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               35% 35-44\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               15% 45-54\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               8% 55+\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                               Adult employees                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Schrager et al. 2017^[@bibr50-2055207619839883]^ USA                                                                  Academic emergency medicine residency                                                                    Prospective cohort (pre- and post- uncontrolled pilot)                                                        *n* = 30\                                                                                                                                 Wearable activity monitor and smartphone app (or website)                       Wrist-worn Fitbit Flex activity monitor (Fitbit, USA) used with Fitbit app and/or website                                                                                                           No control or comparison group                                                                          PA        Days per week with ≥30 min PA\                                                                                                                        Days per week with ≥10,000 steps or ≥30 min of active time (as measured by Fitbit at one month)\                                                                                       6 months
                                                                                                                                                                                                                                                                                                                                               53% M, 47% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**SR**)                                                                                                                                              Qualitative outcomes (survey) -- adoption and use of device, measures of wellness, changes in PA behaviour                                                                             
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                               Median 28 years (IQR = 4.0)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                               Physicians on a single site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Simons et al. 2018 (app development and feasibility)^[@bibr64-2055207619839883]^\                                     Multiple workplaces in Flanders, Belgium (including retail, catering, social employment and factories)   Study 2, 2018b = Cluster RCT (study 1, 2018a was a qualitative evaluation and impact on PA/SB not reported)   *n* = 130 (29 clusters)\                                                                                                                  Wearable activity monitor and smartphone app                                    Wrist-worn Fitbit Charge activity monitor (Fitbit, USA) used with 'Active Coach' app for monitoring PA                                                                                              Educational brochure on PA only (generic information)                                                   PA        Daily minutes of light, moderate and vigorous intensity PA\                                                                                           Daily steps (from Fitbit)\                                                                                                                                                             21 weeks
  Simons et al. 2018 (results of RCT)^[@bibr65-2055207619839883]^\                                                                                                                                                                                                                                                                             49% M, 51% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**OB** - ActiGraph™ GT-3x+ accelerometer)                                                                                                            Self-reported context-specific PA (IPAQ)\                                                                                                                                              
  Belgium                                                                                                                                                                                                                                                                                                                                      Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Psychosocial variables: social support, attitude (perceived benefits and barriers), self-efficacy, knowledge and intentions\                                                           
                                                                                                                                                                                                                                                                                                                                               IG: 24.8±3.1\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Engagement: usage statisticsProcess evaluation interviews: Opinions on Fitbit and app (e.g. usability, preferred features)                                                             
                                                                                                                                                                                                                                                                                                                                               CG: 25.1±3.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               Lower educated (i.e. no university or college degree) working young adults, not meeting PA guidelines at baseline (\<150 min MVPA/week)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Skogstad et al. 2016^[@bibr51-2055207619839883]^ Norway                                                               Road maintenance enterprise                                                                              Prospective cohort (pre- and post- uncontrolled)                                                              *n* = 121\                                                                                                                                Wearable activity monitor (linked with website)                                 Wrist-worn Tappa® activity monitor/ accelerometer used with associated website (Dytt®) for step tracking.Rewards given for best performances.                                                       No control or comparison group                                                                          PA        Weekly exercise frequency and duration\                                                                                                               Aerobic fitness (maximal oxygen uptake, VO~2~ max, ml/kg/min)\                                                                                                                         8 weeks (approx.)
                                                                                                                                                                                                                                                                                                                                               64% M, 36% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**SR**)                                                                                                                                              Systolic and diastolic BP (mm Hg)\                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Resting heart rate\                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                               M = 41.8±12.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Lipids (total, HDL and LDL cholesterol)\                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               F = 42.6±12.5\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        C-reactive protein (CRP)\                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                               24% road workers, 76% office workers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Glycosylated haemoglobin (HbA1c)                                                                                                                                                       

  Slootmaker et al. 2009^[@bibr52-2055207619839883]^ Netherlands                                                        8 worksites surrounding Amsterdam (mainly office settings)                                               RCT                                                                                                           *n* = 102\                                                                                                                                Wearable activity monitor (linked with website)                                 Belt-worn 'AM 101' activity monitor/ accelerometer (PAM BV, Netherlands) used with associated website (PAM COACH).                                                                                  Educational booklet on PA only                                                                          PA + SB   Weekly PA and sedentary time -- weekly minutes of light, moderate and vigorous intensity activity and sedentary minutes\                              Self-reported determinants of PA -- including behavioural intention, attitude, social influence, self-efficacy, knowledge of PA recommendations\                                       8 months
                                                                                                                                                                                                                                                                                                                                               40% M, 60% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (**SR** -- assessed by the AQuAA questionnaire)                                                                                                       Aerobic fitness (maximal oxygen uptake, VO~2~ max, ml/kg/min)\                                                                                                                         
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Body composition -- body weight and height (BMI), waist and hip circumference, skin fold thickness (% body fat)                                                                        
                                                                                                                                                                                                                                                                                                                                               IG: 32.5±3.4\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               CG: 31.2±3.5\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               Mainly office workers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Thorndike et al. 2014^[@bibr53-2055207619839883]^ USA                                                                 Healthcare organisation (Massachusetts General Hospital)                                                 Phase 1 = RCT Phase 2 = team-based prospective cohort (pre- and post- uncontrolled)                           *n* = 104\                                                                                                                                Wearable activity monitor (linked with website)                                 Fitbit activity monitor (Fitbit, USA) used with Fitbit website.\                                                                                                                                    Phase 1 -- blinded activity monitor (no access to website).\                                            PA        Daily step count (phase 1 median and mean steps/day, phase 2 mean steps/day)\                                                                         Proportion of days activity monitor was worn (i.e. compliance)\                                                                                                                        12 weeks
                                                                                                                                                                                                                                                                                                                                               46% M, 54% F\                                                                                                                                                                                                             Gift card lottery for wearing device (phase 1) and highest steps (phase 2).\                                                                                                                        Gift card lottery and workplace initiatives (as intervention group).\                                             (**OB** -- step data from Fitbit)                                                                                                                     Weight\                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                      Workplace initiatives: access to fitness centres, personal training and nutritionists, weekly healthy lunch                                                                                         Phase 2 -- no control or comparison group                                                                                                                                                                                                                               BMI\                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               Mean and range (SD not reported)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Waist circumference\                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               IG: 29 (23--36)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Systolic and diastolic BP\                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                               CG: 29 (25--37)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Lipids (total, HDL and LDL cholesterol)\                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               Physicians-in-training                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Use/engagement with the wider wellness programme (e.g. fitness centre, nutrition)                                                                                                      

  Torquati et al. 2018^[@bibr66-2055207619839883]^ Australia                                                            Two metropolitan hospitals in Brisbane (private and public)                                              Prospective cohort (pre- and post- uncontrolled pilot)                                                        *n* = 47\                                                                                                                                 Smartphone app                                                                  Smartphone app for PA and diet with non-interactive pedometer and dedicated Facebook group                                                                                                          No control or comparison group                                                                          PA + SB   Time spent sedentary and in light activity and MVPA\                                                                                                  Diet behaviour: Food Frequency Questionnaire (FFQ)\                                                                                                                                    6 months
                                                                                                                                                                                                                                                                                                                                               13% M, 87% F\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Daily steps\                                                                                                                                          Weight\                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               Age 41.4±12.1\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  (**OB** - ActiGraph™ GT-3x+ accelerometer)                                                                                                            BMI\                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               Nurses and nursing managers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Waist circumference\                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Blood pressure\                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Self-rated health\                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     PA and diet self-efficacy\                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Social support\                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Feasibility outcomes (including qualitative interviews): reach, adoption (use) and implementation                                                                                      

  van Dantzig et al. 2013^[@bibr54-2055207619839883]^\                                                                  Offices at various companies in Netherlands (no further detail given)                                    Experiment 2 = RCT (experiment 1 was a small qualitative evaluation and impact on PA/SB not reported)         *n* = 86\                                                                                                                                 Wearable activity monitor (linked with website, and persuasive text messages)   Clip-on commercial activity monitor (tri-axial accelerometer, model not stated) linked with personal web page for viewing PA data.\                                                                 Activity monitor only.\                                                                                 SB        Computer activity (minutes, proxy for SB)\                                                                                                            Engagement with the intervention (proportion of text messages read)                                                                                                                    6 weeks
  Netherlands                                                                                                                                                                                                                                                                                                                                  60% M, 40% F\                                                                                                                                                                                                             Timely persuasive text messages on smartphones.                                                                                                                                                     No text messages.                                                                                                 Physical activity (minutes)\                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                               Age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            (**OB** -- computer activity from computer software; PA from activity monitor)                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                               IG: 44.5±7.9\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               CG: 44.3±8.0\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                               Sedentary office workers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Yeung et al. 2017^[@bibr59-2055207619839883]^ USA                                                                     Academic hospital residency (Cincinnati, Ohio)                                                           Prospective cohort (pre- and post- uncontrolled crossover study)                                              *n* = 86\                                                                                                                                 Wearable activity monitor and smartphone app (or website)                       Wrist-worn Fitbit Flex (Fitbit, USA) used with Fitbit app and/or website for monitoring steps (weeks 1--4 blinded, weeks 5--8 unblinded). Optional in-app activity tracking group for weeks 5--8.   No control or comparison group                                                                          PA        Daily steps (comparison of blinded vs. unblinded periods)\                                                                                            Proportion of participants achieving ≥10,000 steps/day                                                                                                                                 8 weeks
                                                                                                                                                                                                                                                                                                                                               38% M, 62% F^b^\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                (**OB** -- step data from Fitbit)                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                               Age^b^\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                               62% 21--30\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                               31% 31--40\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                               5% 41--50\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                               Internal medicine residents                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

M: male; F: female; IG: intervention group; CG: control/comparison group; FTE: full time equivalent; PA: physical activity; SB: sedentary behaviour; OB: objective; SR: self-reported; QoL: quality of life; RCT: randomised controlled trial; ± or SD: standard deviation; MVPA: moderate to vigorous physical activity; BP: blood pressure; BMI: body mass index; MET: metabolic equivalent; IPAQ: international physical activity questionnaire; QQ: Quantity and Quality questionnaire; IQR: Interquartile Range; HDL: high-density lipoprotein; LDL: low-density lipoprotein; AQuAA: Activity Questionnaire for Adolescents and Adults; CDC: Centers for Disease Control and Prevention

**^a^**Tools may be referred to as activity monitors or trackers in the literature; the term 'monitor' is used here for consistency.

**^b^**Yeung et al. and Olsen et al. report gender and age of study completers only.

The number of participants ranged from 20 in a feasibility cohort study,^[@bibr58-2055207619839883]^ to over 69,000 in a large international cohort study.^[@bibr41-2055207619839883]^ The majority of studies targeted sedentary, office-based employees. Of the 25 studies, 16 had a markedly higher proportion of female (≥60%) than male participants.^[@bibr42-2055207619839883][@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883]--[@bibr46-2055207619839883],[@bibr48-2055207619839883],[@bibr49-2055207619839883],[@bibr52-2055207619839883],[@bibr57-2055207619839883][@bibr58-2055207619839883][@bibr59-2055207619839883][@bibr60-2055207619839883][@bibr61-2055207619839883][@bibr62-2055207619839883]--[@bibr63-2055207619839883],[@bibr66-2055207619839883]^

The most common study designs were individual RCTs (*n* = 10)^[@bibr39-2055207619839883],[@bibr40-2055207619839883],[@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883][@bibr46-2055207619839883][@bibr47-2055207619839883]--[@bibr48-2055207619839883],[@bibr52-2055207619839883],[@bibr54-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883]^ and pre-post prospective cohort studies (*n* = 10).^[@bibr41-2055207619839883],[@bibr49-2055207619839883][@bibr50-2055207619839883]--[@bibr51-2055207619839883],[@bibr55-2055207619839883][@bibr56-2055207619839883][@bibr57-2055207619839883][@bibr58-2055207619839883]--[@bibr59-2055207619839883],[@bibr61-2055207619839883],[@bibr66-2055207619839883]^ One study used a combination of these designs in two phases.^[@bibr53-2055207619839883]^ Other designs included cluster RCTs,^[@bibr37-2055207619839883],[@bibr38-2055207619839883],[@bibr65-2055207619839883]^ a parallel group uncontrolled randomised trial,^[@bibr63-2055207619839883]^ and a prospective cluster trial with an asynchronous control group.^[@bibr42-2055207619839883]^ Study duration varied greatly, with length of follow-up ranging from 6 weeks to 12 months.

Assessing the effectiveness, feasibility and/or acceptability of mHealth technology for PA promotion was the primary aim of 16 studies.^[@bibr39-2055207619839883],[@bibr40-2055207619839883],[@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883][@bibr46-2055207619839883][@bibr47-2055207619839883][@bibr48-2055207619839883][@bibr49-2055207619839883][@bibr50-2055207619839883]--[@bibr51-2055207619839883],[@bibr53-2055207619839883],[@bibr57-2055207619839883][@bibr58-2055207619839883]--[@bibr59-2055207619839883],[@bibr62-2055207619839883],[@bibr63-2055207619839883],[@bibr65-2055207619839883]^ Six studies targeted both PA and SB in a single intervention^[@bibr41-2055207619839883],[@bibr42-2055207619839883],[@bibr52-2055207619839883],[@bibr55-2055207619839883],[@bibr56-2055207619839883],[@bibr60-2055207619839883],[@bibr66-2055207619839883]^ and three studies aimed to reduce SB (but also included PA as an outcome measure).^[@bibr37-2055207619839883],[@bibr38-2055207619839883],[@bibr54-2055207619839883],[@bibr61-2055207619839883]^ Although recruitment and/or delivery of the intervention took place in the workplace in all cases, 24 of the 25 studies used mHealth as a wider lifestyle intervention, including both workplace and non-workplace activity. Only one study, designed to reduce SB, was based exclusively in the workplace.^[@bibr54-2055207619839883]^

The main mHealth tools used were wearable activity monitors or trackers (n = 11),^39,[@bibr40-2055207619839883],[@bibr42-2055207619839883],[@bibr46-2055207619839883][@bibr47-2055207619839883][@bibr48-2055207619839883]--[@bibr49-2055207619839883],[@bibr51-2055207619839883][@bibr52-2055207619839883][@bibr53-2055207619839883]--[@bibr54-2055207619839883],[@bibr57-2055207619839883],[@bibr63-2055207619839883]^ smartphone apps (*n* = 6),^[@bibr41-2055207619839883],[@bibr43-2055207619839883][@bibr44-2055207619839883]--[@bibr45-2055207619839883],[@bibr62-2055207619839883],[@bibr66-2055207619839883]^ or a combination of the two (*n* = 8).^37,[@bibr38-2055207619839883],[@bibr50-2055207619839883],[@bibr55-2055207619839883],[@bibr56-2055207619839883],[@bibr58-2055207619839883][@bibr59-2055207619839883][@bibr60-2055207619839883]--[@bibr61-2055207619839883],[@bibr65-2055207619839883]^ Some studies had additional mHealth and technology intervention components, including motivational or persuasive text messaging^[@bibr43-2055207619839883],[@bibr46-2055207619839883],[@bibr54-2055207619839883]^ or e-mails,^[@bibr61-2055207619839883]^ computer software or websites linked to the activity monitor,^[@bibr39-2055207619839883],[@bibr40-2055207619839883],[@bibr42-2055207619839883],[@bibr46-2055207619839883][@bibr47-2055207619839883]--[@bibr48-2055207619839883],[@bibr51-2055207619839883][@bibr52-2055207619839883][@bibr53-2055207619839883]--[@bibr54-2055207619839883],[@bibr57-2055207619839883][@bibr58-2055207619839883]--[@bibr59-2055207619839883],[@bibr63-2055207619839883]^ and dedicated social media groups.^[@bibr66-2055207619839883]^ Eleven studies assessed mHealth as a standalone intervention,^[@bibr41-2055207619839883],[@bibr46-2055207619839883],[@bibr49-2055207619839883],[@bibr50-2055207619839883],[@bibr52-2055207619839883],[@bibr54-2055207619839883],[@bibr59-2055207619839883],[@bibr60-2055207619839883],[@bibr63-2055207619839883],[@bibr65-2055207619839883],[@bibr66-2055207619839883]^ whereas 14 studies used mHealth in the context of a multi-component workplace health or PA programme.^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883]--[@bibr40-2055207619839883],[@bibr42-2055207619839883][@bibr43-2055207619839883][@bibr44-2055207619839883]--[@bibr45-2055207619839883],[@bibr47-2055207619839883],[@bibr48-2055207619839883],[@bibr51-2055207619839883],[@bibr53-2055207619839883],[@bibr55-2055207619839883][@bibr56-2055207619839883][@bibr57-2055207619839883]--[@bibr58-2055207619839883],[@bibr61-2055207619839883],[@bibr62-2055207619839883]^ Among the multi-component programmes in particular, interventions were diverse and additional components included educational materials on health and PA,^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883]--[@bibr40-2055207619839883],[@bibr43-2055207619839883],[@bibr47-2055207619839883],[@bibr48-2055207619839883],[@bibr55-2055207619839883],[@bibr56-2055207619839883],[@bibr58-2055207619839883],[@bibr61-2055207619839883]^ managerial support,^[@bibr37-2055207619839883],[@bibr38-2055207619839883]^ financial incentives or rewards,^[@bibr39-2055207619839883],[@bibr40-2055207619839883],[@bibr44-2055207619839883],[@bibr45-2055207619839883],[@bibr51-2055207619839883],[@bibr53-2055207619839883],[@bibr55-2055207619839883][@bibr56-2055207619839883]--[@bibr57-2055207619839883],[@bibr62-2055207619839883]^ shared active workstations,^[@bibr42-2055207619839883]^ online or telephone counselling,^[@bibr47-2055207619839883],[@bibr48-2055207619839883],[@bibr58-2055207619839883]^ personalised feedback on activity,^[@bibr55-2055207619839883][@bibr56-2055207619839883]--[@bibr57-2055207619839883]^ wellness education delivered in the workplace,^[@bibr42-2055207619839883],[@bibr53-2055207619839883],[@bibr61-2055207619839883]^ group-based action planning,^[@bibr61-2055207619839883]^ and access to personal training and nutritionists.^[@bibr53-2055207619839883]^ Further detail on intervention content is given in [Table 2](#table2-2055207619839883){ref-type="table"}.

###### 

Summary of intervention components.

![](10.1177_2055207619839883-table2)

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Intervention description\                                                                                                                                                                                                                                                                                                                                                                                              Duration of intervention                                                  Frequency of intervention (if applicable)                                                                                  Theoretical basis of intervention                                                                                                            Behaviour change techniques (BCTs) included (whole intervention)                                                                    
                                                                                                             Standalone mHealth (**SA**) or multi-component programme (**MC**)?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  ---------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------ ------- ------- ------- ------- ------- ---------------- ------- -----------------------------------------------------
  Brakenridge et al. 2016^[@bibr37-2055207619839883]^; Brakenridge et al. 2016^[@bibr38-2055207619839883]^   Wearable activity monitor and smartphone app for feedback on sitting, standing, stepping, sitting breaks, posture and sleep.\                                                                                                                                                                                                                                                                                          12 months (although main focus, e.g. e-mails was in the first 12 weeks)   *Ad lib* wear of activity monitor and use of smartphone app.\                                                              None stated                                                                                                                                  **?**                                                              **Y**   **Y**   **Y**   **N**   **N**   **N**            **Y**   Information on where and when to perform behaviour
                                                                                                             **MC**: organisational support (e-mails, educational materials)                                                                                                                                                                                                                                                                                                                                                                                                                                  Fortnightly e-mails for first 12 weeks.                                                                                                                                                                                                                                                                                                                                                                     

  Finkelstein et al. 2015^[@bibr39-2055207619839883]^; Finkelstein et al. 2016^[@bibr40-2055207619839883]^   Wearable activity monitor used with website including social components.\                                                                                                                                                                                                                                                                                                                                              6 months                                                                  Daily wear of activity monitor.\                                                                                           Economic theory and Theory of Reasoned Action                                                                                                **Y**                                                              **Y**   **N**   **Y**   **Y**   **Y**   **Y**            **Y**   
                                                                                                             **MC:** 2 of the 3 intervention groups earned weekly incentives for step count (cash vs. charity)\                                                                                                                                                                                                                                                                                                                                                                                               Incentives for weekly step counts distributed every 4-6 weeks.                                                                                                                                                                                                                                                                                                                                              
                                                                                                             Educational booklets on PA.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Ganesan et al. 2016^[@bibr41-2055207619839883]^                                                            'Stepathlon' mobile app (also available as website). Participants self-entered daily activity data and steps from pedometers. Included personalised tools for self-monitoring PA and dietary intake, quizzes, motivational e-mails, online community and chat for interactive advice/expert guidance, social networking, competitions and health information. Also gamification -- race around a virtual world map.\   100 days                                                                  Daily e-mails to encourage daily activity data entry.                                                                      None stated                                                                                                                                  **?**                                                              **Y**   **Y**   **Y**   **N**   **Y**   **Y**            **Y**   
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Gilson et al. 2016^[@bibr55-2055207619839883]^;Gilson et al. 2017^[@bibr56-2055207619839883]^              Wearable activity monitor used with associated smartphone app for monitoring steps and diet.\                                                                                                                                                                                                                                                                                                                          20 weeks                                                                  *Ad lib* wear of activity monitor and use of smartphone app.\                                                              None stated                                                                                                                                  **Y**                                                              **Y**   **N**   **Y**   **Y**   **Y**   **N**            **Y**   Information on where and when to perform behaviour\
                                                                                                             **MC**: Part of the 'Shifting Gears' programme. Earning points and financial rewards for attaining step goals and logging diet.\                                                                                                                                                                                                                                                                                                                                                                 Personalised feedback and guidance from researcher every 4 weeks.\                                                                                                                                                                                                                                                                                                                                          Action planning\
                                                                                                             Educational materials on PA and diet.\                                                                                                                                                                                                                                                                                                                                                                                                                                                           Rewards at end of programme.                                                                                                                                                                                                                                                                                                                                                                                Graded tasks
                                                                                                             Personalised feedback and guidance from researchers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Jones 2016^[@bibr42-2055207619839883]^                                                                     Wearable activity monitor used with software installed on work computers. Included monitoring progress towards step and activity goals, competing against colleagues and earning incentives and awards for meeting step targets.\                                                                                                                                                                                      6 months                                                                  Daily wear of activity monitor.Use of active desks for at least 30 min a day, 5 days a week. Monthly wellness education.   Socio-Ecological Model                                                                                                                       **Y**                                                              **Y**   **N**   **Y**   **Y**   **Y**   **Y**            **Y**   Environmental restructuring
                                                                                                             **MC:** One intervention group used shared active workstations.Group wellness education delivered in the workplace.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Koyle 2013^[@bibr43-2055207619839883]^                                                                     'Adidas miCoach' smartphone app with integrated accelerometer. Motivational text messages tailored based on initial app-delivered fitness test and walking logs.\                                                                                                                                                                                                                                                      6 weeks                                                                   *Ad lib* use of smartphone app. Weekly motivational text messages.                                                         Self-Efficacy Theory (part of Social Cognitive Theory)                                                                                       **Y**                                                              **Y**   **Y**   **Y**   **N**   **N**   **N**            **Y**   Action planning
                                                                                                             **MC:** Part of a health promotion programme including educational materials on PA.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Losina et al. 2017^[@bibr57-2055207619839883]^                                                             Wearable activity monitor used with websites to monitor steps and PA, including individual and team progress.\                                                                                                                                                                                                                                                                                                         24 weeks                                                                  Daily wear of activity monitor.\                                                                                           Behavioural economic theory                                                                                                                  **Y**                                                              **Y**   **N**   **Y**   **Y**   **Y**   **N**            **N**   Graded tasks\
                                                                                                             **MC:** Monetary incentives (individual and team) for meeting PA goals. Personalised weekly e-mails for feedback on MVPA.                                                                                                                                                                                                                                                                                                                                                                        Weekly financial rewards.\                                                                                                                                                                                                                                                                                                                                                                                  Shaping
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Weekly feedback e-mails.                                                                                                                                                                                                                                                                                                                                                                                    

  Neil-Sztramko et al. 2017^[@bibr58-2055207619839883]^                                                      Wearable activity monitor used with associated app and/or website to monitor steps and PA.\                                                                                                                                                                                                                                                                                                                            12 weeks                                                                  *Ad lib* wear of activity monitor and use of smartphone app.\                                                              Health Action Process Approach (HAPA)                                                                                                        **Y**                                                              **Y**   **N**   **Y**   **N**   **Y**   **N**            **Y**   Barrier identification/problem solving
                                                                                                             **MC**: Individualised behavioural counselling (telephone/online -- all participants chose telephone).                                                                                                                                                                                                                                                                                                                                                                                           8 counselling sessions over 12 weeks.                                                                                                                                                                                                                                                                                                                                                                       

  Patel et al. 2016^[@bibr44-2055207619839883]^                                                              'Moves' smartphone app with integrated accelerometer. Feedback on steps.\                                                                                                                                                                                                                                                                                                                                              13 weeks                                                                  *Ad lib* use of smartphone app (instructed to carry phone when active).\                                                   Behavioural economics -- immediate vs. delayed gratification, prospect theory and regret aversion.                                           **Y**                                                              **?**   **N**   **Y**   **Y**   **N**   **N**            **N**   Action planning\
                                                                                                             **MC:** The three intervention groups received differently framed financial incentives for achieving step goals (gain, lottery and loss).                                                                                                                                                                                                                                                                                                                                                        Daily feedback and incentives.                                                                                                                                                                                                                                                                                                                                                                              Prompt anticipated regret

  Patel et al. 2016^[@bibr45-2055207619839883]^                                                              'Moves' smartphone app with integrated accelerometer. Feedback on steps.\                                                                                                                                                                                                                                                                                                                                              13 weeks                                                                  *Ad lib* use of smartphone app (instructed to carry phone when active).\                                                   Behavioural economics; variable reinforcement; social behaviour change theories                                                              **Y**                                                              **?**   **N**   **Y**   **Y**   **N**   **Y**            **N**   Action planning
                                                                                                             **MC:** The three intervention groups received differently framed financial incentives for achieving step goals (individual, team and combined).                                                                                                                                                                                                                                                                                                                                                 Daily feedback and incentives.                                                                                                                                                                                                                                                                                                                                                                              

  Poirier et al. 2016^[@bibr46-2055207619839883]^                                                            Wearable activity monitor used with website (data transmitted wirelessly) for monitoring steps. Tailored goals based on activity. Motivational electronic messages (optional). Virtual rewards, social messaging and competitions.\                                                                                                                                                                                    6 weeks                                                                   Daily wear of activity monitor.\                                                                                           Tailored, adaptive goals based on behavioural economics and operant shaping.                                                                 **Y**                                                              **Y**   **Y**   **Y**   **Y**   **Y**   **Y**            **N**   Shaping\
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Messages up to 4 times/day (optional).                                                                                                                                                                                                                                                                                                                                                                      Information about others' approval

  Reijonsaari et al. 2009^[@bibr47-2055207619839883]^; Reijonsaari et al. 2012^[@bibr48-2055207619839883]^   Wearable activity monitor used with website for goal-setting and PA monitoring.\                                                                                                                                                                                                                                                                                                                                       12 months                                                                 Daily wear of activity monitor.\                                                                                           None stated                                                                                                                                  **Y**                                                              **Y**   **Y**   **Y**   **N**   **Y**   **N**            **Y**   
                                                                                                             **MC:** Personalised distance counselling and support (online and telephone). Written information on fitness test results, PA and health.                                                                                                                                                                                                                                                                                                                                                        Phone call or message from coach if did not log on to website every 2 weeks to upload PA data.                                                                                                                                                                                                                                                                                                              

  Rowe-Roberts et al. 2014^[@bibr49-2055207619839883]^                                                       Wearable activity monitor for monitoring steps. Participants were offered an optional additional device for friends/family midway through the intervention for social support and competition.\                                                                                                                                                                                                                        7 months                                                                  Daily wear of activity monitor.                                                                                            None stated (although mentioned Transtheoretical Model in discussion)                                                                        **N**                                                              **Y**   **N**   **N**   **N**   **Y**   **Y**            **N**   
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Schrager et al. 2017^[@bibr50-2055207619839883]^                                                           Wearable activity monitor used with associated app and/or website to view and monitor data.\                                                                                                                                                                                                                                                                                                                           1 month intervention/active monitoring and optional use up to 6 months    Daily wear of activity monitor.                                                                                            None stated (although key behaviour change techniques reported in discussion)                                                                **?**                                                              **Y**   **?**   **?**   **?**   **?**   **?**            **N**   
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Skogstad et al. 2016^[@bibr51-2055207619839883]^                                                           Wearable activity monitor used with associated website to monitor PA and compete against colleagues individually and in teams. Gamification -- virtual internet mountain track.\                                                                                                                                                                                                                                       8 weeks                                                                   Daily wear of activity monitor and *ad lib* use of website.\                                                               None stated                                                                                                                                  **N**                                                              **Y**   **N**   **N**   **Y**   **N**   **Y**            **N**   
                                                                                                             **MC:** Part of an organised 8-week workplace PA programme ('Dytt®'). Rewards given for best performances.                                                                                                                                                                                                                                                                                                                                                                                       Weekly PA results posted on intranet.\                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Rewards at end of programme.                                                                                                                                                                                                                                                                                                                                                                                

  Slootmaker et al. 2009^[@bibr52-2055207619839883]^                                                         Wearable activity monitor used with website to monitor PA (data uploaded via docking station and software on work computers). Website provided tailored goal-setting and PA advice. Comparison of PA scores with peers.\                                                                                                                                                                                               3 months                                                                  Daily wear of activity monitor.\                                                                                           None stated                                                                                                                                  **Y**                                                              **Y**   **N**   **Y**   **N**   **N**   **Y**            **Y**   Action planning\
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           *Ad lib* use of website.                                                                                                                                                                                                                                                                                                                                                                                    Graded tasks

  Thorndike et al. 2014^[@bibr53-2055207619839883]^                                                          Wearable activity monitor used with website to monitor steps, PA, weight and diet. Included gamification -- virtual 'avatar' on activity monitor screen that changed size with varying level of PA/SB.\                                                                                                                                                                                                                12 weeks (phase 1 = 6 weeks, phase 2 = 6 weeks)                           Daily wear of activity monitor and *ad lib* use of website.\                                                               None stated                                                                                                                                  **N**                                                              **Y**   **N**   **Y**   **Y**   **N**   **Y**            **N**   
                                                                                                             Phase 1 = individual monitoring\                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Weekly e-mail reminders to charge device and with details of gift card lottery.                                                                                                                                                                                                                                                                                                                             
                                                                                                             Phase 2 = team-based steps competition\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                             **MC:** Part of a 10-week, team-based worksite wellness programme ('BeFit') -- included access to personal training and nutritionists.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                             Lottery to reward device wear and attainments (highest steps).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  van Dantzig et al. 2013^[@bibr54-2055207619839883]^                                                        Wearable activity monitor linked with personal web page to monitor activity patterns. Timely, persuasive text messages on smartphone during prolonged periods of sitting (detected by computer software).\                                                                                                                                                                                                             6 weeks                                                                   Daily wear of activity monitor.\                                                                                           Intervention based on four of six social influence strategies^[@bibr72-2055207619839883]^ -- authority, commitment, consensus and scarcity   **N**                                                              **Y**   **Y**   **Y**   **N**   **N**   **N**            **N**   
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Text messages sent every 30 min of uninterrupted computer activity (up to a maximum of three messages/ day).                                                                                                                                                                                                                                                                                                

  Yeung et al. 2017^[@bibr59-2055207619839883]^                                                              Wearable activity monitor used with associated app and/or website for monitoring steps (weeks 1--4 blinded, weeks 5--8 unblinded). Optional resident-only activity tracking group to 'connect and compete' with peers for weeks 5--8.\                                                                                                                                                                                 8 weeks                                                                   Daily wear of activity monitor.\                                                                                           None stated                                                                                                                                  **Y**                                                              **Y**   **N**   **Y**   **N**   **N**   **Y optional**   **N**   Action planning
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           *Ad lib* use of app/website.                                                                                                                                                                                                                                                                                                                                                                                

  Gremaud et al. 2018^[@bibr60-2055207619839883]^                                                            Wearable activity monitor used with 'MapTrek' app (smartphone or web-based) for gamification of walking, including virtual 'avatar' and races, including a social competitive element and automated text messages based on PA.\                                                                                                                                                                                        10 weeks                                                                  Daily wear of activity monitor.\                                                                                           Cognitive evaluation/self-determination theories and Social Cognitive Theory                                                                 **Y**                                                              **Y**   **Y**   **Y**   **Y**   **N**   **Y**            **N**   
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           *Ad lib* use of smartphone app.                                                                                                                                                                                                                                                                                                                                                                             

  Olsen et al. 2018^[@bibr61-2055207619839883]^                                                              Wearable activity monitor used with associated app for self-monitoring, social support and prompts to reduce SB.\                                                                                                                                                                                                                                                                                                      6 weeks                                                                   *Ad lib* wear of activity monitor and use of smartphone app.\                                                              Social Cognitive Theory                                                                                                                      **Y**                                                              **Y**   **Y**   **Y**   **N**   **Y**   **Y**            **Y**   Action planning\
                                                                                                             **MC:** Group-based goal-setting, action planning and problem solving session delivered in workplace.\                                                                                                                                                                                                                                                                                                                                                                                           Weekly e-mails.\                                                                                                                                                                                                                                                                                                                                                                                            Barrier identification/problem solving\
                                                                                                             Weekly e-mail reminders and information resources.\                                                                                                                                                                                                                                                                                                                                                                                                                                              One group-based session and one seminar.                                                                                                                                                                                                                                                                                                                                                                    Information on where and when to perform behaviour\
                                                                                                             Healthy living seminar delivered in workplace (week 4).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Instruction on how to perform behaviour

  Patel et al. 2018^[@bibr62-2055207619839883]^                                                              'Moves' smartphone app with integrated accelerometer.\                                                                                                                                                                                                                                                                                                                                                                 13 weeks                                                                  *Ad lib* use of smartphone app (instructed to carry phone when active).\                                                   Behavioural economics -- immediate vs. delayed gratification, prospect theory and regret aversion.                                           **Y**                                                              **?**   **N**   **Y**   **Y**   **N**   **N**            **N**   Action planning\
                                                                                                             Feedback on steps.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Daily feedback and incentives.                                                                                                                                                                                                                                                                                                                                                                              Prompt anticipated regret
                                                                                                             **MC**: The three intervention groups received differently framed financial incentives for achieving step goals (high frequency small reward lottery, jackpot lottery and combined lottery).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Reed et al. 2018^[@bibr63-2055207619839883]^                                                               Wearable activity monitor linked with website for monitoring PA and steps and taking part in one of three challenges (individual, friend or team)\                                                                                                                                                                                                                                                                     6 weeks                                                                   Daily wear of activity monitor.\                                                                                           Social behaviour change theories including self-presentation theory                                                                          **?**                                                              **Y**   **N**   **Y**   **N**   **N**   **Y**            **N**   
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           *Ad lib* use of website.                                                                                                                                                                                                                                                                                                                                                                                    

  Simons et al. 2018^[@bibr64-2055207619839883]^; Simons et al. 2018^[@bibr65-2055207619839883]^             Wearable activity monitor used with 'Active Coach' smartphone app for goal-setting, self-monitoring, and tailored information to promote PA\                                                                                                                                                                                                                                                                           9 weeks                                                                   Daily use of activity monitor and app encouraged                                                                           Self-determination theory (and BCTs identified during app development)                                                                       **Y**                                                              **Y**   **Y**   **Y**   **N**   **Y**   **N**            **Y**   Barrier identification/problem solving\
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Graded tasks\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Information on where and when to perform behaviour\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Instruction on how to perform behaviour

  Torquati et al. 2018^[@bibr66-2055207619839883]^                                                           Smartphone app for PA and diet (goal-setting) with non-interactive pedometer (self-monitoring) and dedicated Facebook group (social support)\                                                                                                                                                                                                                                                                          3 months                                                                  *Ad lib* use of smartphone app and Facebook group                                                                          Social Cognitive Theory, goal-setting theory and control theory                                                                              **Y**                                                              **Y**   **N**   **N**   **N**   **Y**   **Y**            **N**   
                                                                                                             **SA**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BCT: Behaviour Change Technique; SA: Standalone mHealth; MC: Multi-Component programme; Y: Yes, included in intervention; N: No, not included in intervention;?: unclear or difficult to determine whether included from available intervention description; PA: Physical Activity; SB: Sedentary Behaviour; MVPA: Moderate to Vigorous Physical Activity

Intervention duration ranged from 1 to 12 months. Frequency of delivery of the intervention components was variable but daily wear of activity monitors was encouraged in most studies. Fifteen studies reported that the intervention was based on a named behaviour change theory and/or principles of behavioural economics.^[@bibr39-2055207619839883],[@bibr40-2055207619839883],[@bibr42-2055207619839883][@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883]--[@bibr46-2055207619839883],[@bibr54-2055207619839883],[@bibr57-2055207619839883],[@bibr58-2055207619839883],[@bibr60-2055207619839883][@bibr61-2055207619839883][@bibr62-2055207619839883][@bibr63-2055207619839883][@bibr64-2055207619839883][@bibr65-2055207619839883]--[@bibr66-2055207619839883]^ A further two studies alluded to behaviour change techniques or theory in their discussion,^[@bibr49-2055207619839883],[@bibr50-2055207619839883]^ and eight studies had no clear theoretical basis.^[@bibr37-2055207619839883],[@bibr38-2055207619839883],[@bibr41-2055207619839883],[@bibr47-2055207619839883],[@bibr48-2055207619839883],[@bibr51-2055207619839883][@bibr52-2055207619839883]--[@bibr53-2055207619839883],[@bibr55-2055207619839883],[@bibr56-2055207619839883],[@bibr59-2055207619839883]^ The most frequently cited behaviour change theories were the Theory of Reasoned Action,^[@bibr67-2055207619839883]^ the Socio-Ecological Model,^[@bibr68-2055207619839883]^ Social Cognitive Theory and Self-Efficacy,^[@bibr69-2055207619839883]^ Self-Determination Theory,^[@bibr70-2055207619839883]^ other social influence theories such as self-presentation theory and Cialdini's social influence strategies,^[@bibr71-2055207619839883],[@bibr72-2055207619839883]^ and the Health Action Process Approach.^[@bibr73-2055207619839883]^

A control or comparator group was present in 14 of the 25 studies.^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883]--[@bibr40-2055207619839883],[@bibr42-2055207619839883][@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883][@bibr46-2055207619839883][@bibr47-2055207619839883]--[@bibr48-2055207619839883],[@bibr52-2055207619839883][@bibr53-2055207619839883]--[@bibr54-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883],[@bibr65-2055207619839883]^ Of these, six could not be classed as a 'true' control group as the participants received at least a partial mHealth intervention,^[@bibr43-2055207619839883][@bibr44-2055207619839883]--[@bibr45-2055207619839883],[@bibr54-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883]^ and another three studies supplied controls with wearable activity monitors for data collection.^[@bibr42-2055207619839883],[@bibr46-2055207619839883],[@bibr53-2055207619839883]^

Outcome measures of PA and SB were heterogeneous. The most frequently used outcome measures for PA included daily step count, daily or weekly minutes or metabolic equivalent (MET) minutes of total activity or moderate to vigorous PA (MVPA). Other outcomes included exercise frequency and proportion of participants meeting step or PA goals. Studies that assessed SB commonly reported daily or weekly sedentary time, although the one study using an exclusive workplace intervention used computer activity as a proxy for SB.^[@bibr54-2055207619839883]^ Objective PA/SB outcomes were used in 20 studies,^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883]--[@bibr40-2055207619839883],[@bibr42-2055207619839883][@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883]--[@bibr46-2055207619839883],[@bibr49-2055207619839883],[@bibr53-2055207619839883][@bibr54-2055207619839883][@bibr55-2055207619839883][@bibr56-2055207619839883][@bibr57-2055207619839883][@bibr58-2055207619839883][@bibr59-2055207619839883][@bibr60-2055207619839883][@bibr61-2055207619839883][@bibr62-2055207619839883]--[@bibr63-2055207619839883],[@bibr65-2055207619839883],[@bibr66-2055207619839883]^ whilst four studies relied on self-report for the primary measure of PA or SB.^[@bibr47-2055207619839883],[@bibr48-2055207619839883],[@bibr50-2055207619839883][@bibr51-2055207619839883]--[@bibr52-2055207619839883]^ Ganesan and colleagues used pedometer data that was self-entered by participants.^[@bibr41-2055207619839883]^

Study quality {#sec12-2055207619839883}
-------------

A summary of the risk of bias and quality assessment for the included studies is presented in [Table 3](#table3-2055207619839883){ref-type="table"}. Using the EPHPP tool, only one study was judged as 'strong' quality.^[@bibr53-2055207619839883]^ Nine studies were assigned a 'moderate' quality rating,^[@bibr39-2055207619839883],[@bibr40-2055207619839883],[@bibr43-2055207619839883],[@bibr44-2055207619839883],[@bibr46-2055207619839883],[@bibr52-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883],[@bibr63-2055207619839883],[@bibr65-2055207619839883]^ and 15 studies were given a 'weak' rating.^[@bibr37-2055207619839883],[@bibr38-2055207619839883],[@bibr41-2055207619839883],[@bibr42-2055207619839883],[@bibr45-2055207619839883],[@bibr47-2055207619839883][@bibr48-2055207619839883][@bibr49-2055207619839883][@bibr50-2055207619839883]--[@bibr51-2055207619839883],[@bibr54-2055207619839883][@bibr55-2055207619839883][@bibr56-2055207619839883][@bibr57-2055207619839883][@bibr58-2055207619839883]--[@bibr59-2055207619839883],[@bibr61-2055207619839883],[@bibr66-2055207619839883]^ All except two studies were judged as 'weak' in terms of selection bias; participants were typically self-selected employees who volunteered to take part in a wellness programme.^[@bibr50-2055207619839883],[@bibr53-2055207619839883]^ Representativeness and level of participation were unclear in many of the included studies.

###### 

Summary of risk of bias assessment.

![](10.1177_2055207619839883-table3)

                                                                                                             Selection bias   Study design   Confounders   Blinding   Data collection method^a^   Withdrawals and dropouts   Attrition rate^b^                                                                                                             Global rating
  ---------------------------------------------------------------------------------------------------------- ---------------- -------------- ------------- ---------- --------------------------- -------------------------- ----------------------------------------------------------------------------------------------------------------------------- ---------------
  Brakenridge et al. 2016^[@bibr37-2055207619839883]^; Brakenridge et al. 2016^[@bibr38-2055207619839883]^   W                S              S             W          S                           W                          IG: 62% CG: 47% Overall: 54%                                                                                                  **Weak**
  Finkelstein et al. 2015^[@bibr39-2055207619839883]^; Finkelstein et al. 2016^[@bibr40-2055207619839883]^   W                S              S             M          S                           S                          IG1: 21%, IG2: 24%, IG3: 14% CG: 17% Overall: 19%                                                                             **Moderate**
  Ganesan et al. 2016^[@bibr41-2055207619839883]^                                                            W                M              S             M          M                           W                          IG: 47%                                                                                                                       **Weak**
  Gilson et al. 2016^[@bibr55-2055207619839883]^; Gilson et al. 2017^[@bibr56-2055207619839883]^             W                M              W             M          S                           W                          IG: 57%                                                                                                                       **Weak**
  Gremaud et al. 2018^[@bibr60-2055207619839883]^                                                            W                S              S             M          S                           S                          IG: 0% CG: 1% Overall: 1%                                                                                                     **Moderate**
  Jones 2016^[@bibr42-2055207619839883]^                                                                     W                M              W             M          S                           M                          IG1: 32%, IG2: 16% CG: 25% Overall: 24%                                                                                       **Weak**
  Koyle 2013^[@bibr43-2055207619839883]^                                                                     W                S              S             M          M                           S                          IG: 17% CG: 11% Overall: 14%                                                                                                  **Moderate**
  Losina et al. 2017^[@bibr57-2055207619839883]^                                                             W                M              W             M          M                           S                          IG: 3%                                                                                                                        **Weak**
  Neil-Sztramko et al. 2017^[@bibr58-2055207619839883]^                                                      W                M              W             M          S                           S                          IG: 0%                                                                                                                        **Weak**
  Olsen et al. 2018^[@bibr61-2055207619839883]^                                                              W                M              W             M          S                           M                          IG: 39%                                                                                                                       **Weak**
  Patel et al. 2016^[@bibr44-2055207619839883]^                                                              W                S              S             M          M                           S                          IG1: 3%, IG2: 8%, IG3: 4% CG: 4% Overall: 5%                                                                                  **Moderate**
  Patel et al. 2016^[@bibr45-2055207619839883]^                                                              W                S              W             M          M                           S                          IG1: 3%, IG2: 4%, IG3: 3% CG: 6% Overall: 4%                                                                                  **Weak**
  Patel et al. 2018^[@bibr62-2055207619839883]^                                                              W                S              S             M          M                           S                          IG1: 5%, IG2: 5%, IG3: 7% CG: 8% Overall: 6%                                                                                  **Moderate**
  Poirier et al. 2016^[@bibr46-2055207619839883]^                                                            W                S              S             M          S                           S                          IG: 20% CG: 17% Overall: 18%                                                                                                  **Moderate**
  Reed et al. 2018^[@bibr63-2055207619839883]^                                                               W                S              S             M          M                           S                          IG1: 8%, IG2: 0%, IG3: 4% Overall: 4%                                                                                         **Moderate**
  Reijonsaari et al. 2009^[@bibr47-2055207619839883]^; Reijonsaari et al. 2012^[@bibr48-2055207619839883]^   W                S              S             W          S                           M                          IG: 35% CG: 32% Overall: 33%                                                                                                  **Weak**
  Rowe-Roberts et al. 2014^[@bibr49-2055207619839883]^                                                       W                M              W             M          S                           M                          IG: 34%                                                                                                                       **Weak**
  Schrager et al. 2017^[@bibr50-2055207619839883]^                                                           M                M              W             M          W                           M                          IG: 35%                                                                                                                       **Weak**
  Simons et al. 2018^[@bibr64-2055207619839883]^; Simons et al. 2018^[@bibr65-2055207619839883]^             W                S              S             M          S                           S                          IG: 12% CG: 19% Overall: 15%                                                                                                  **Moderate**
  Skogstad et al. 2016^[@bibr51-2055207619839883]^                                                           W                M              S             M          W                           S                          IG: 15%                                                                                                                       **Weak**
  Slootmaker et al. 2009^[@bibr52-2055207619839883]^                                                         W                S              S             M          M                           M                          IG: 26% CG: 18% Overall: 22%                                                                                                  **Moderate**
  Thorndike et al. 2014^[@bibr53-2055207619839883]^                                                          S                M              S             M          S                           S                          Phase 1 IG: 4% CG: 6% Phase 2 IG: 8% Whole trial: 13%                                                                         **Strong**
  Torquati et al. 2018^[@bibr66-2055207619839883]^                                                           W                M              W             M          S                           W                          IG: 74%                                                                                                                       **Weak**
  van Dantzig et al. 2013^[@bibr54-2055207619839883]^                                                        W                S              S             M          W                           S                          Attrition not reported but 85/86 participants appear to have completed the trial based on final data (i.e. 1.2% attrition).   **Weak**
  Yeung et al. 2017^[@bibr59-2055207619839883]^                                                              W                M              W             M          S                           S                          IG: 14%                                                                                                                       **Weak**

S: strong; M: moderate; W: weak; IG: Intervention Group; CG: Control/Comparison Group

**^a^**Validity and reliability of primary outcome. For data collection method, studies were rated as 'strong' if the measure had known validity *and* reliability, 'moderate' if the measure had reasonable validity *or* reliability, and 'weak' if validity and reliability were unknown.

**^b^**Percentage of participants failing to provide data at final follow-up (to nearest whole percentage)

All 25 studies used robust experimental or quasi-experimental designs. Of the 25 studies, 15 reported controlling for important confounders in their design and/or analysis. Ten studies were assigned a 'weak' rating in this domain due to lack of reporting or poor control of confounders in analysis.^[@bibr42-2055207619839883],[@bibr45-2055207619839883],[@bibr49-2055207619839883],[@bibr50-2055207619839883],[@bibr56-2055207619839883][@bibr57-2055207619839883][@bibr58-2055207619839883]--[@bibr59-2055207619839883],[@bibr61-2055207619839883],[@bibr66-2055207619839883]^ No studies received a 'strong' rating for blinding due to the difficulty and impracticality in blinding participants to this type of mHealth intervention. Blinding of outcome assessors was often not described, and two studies were rated as 'weak' in this domain as outcome assessors were reported to be unblinded.^[@bibr37-2055207619839883],[@bibr38-2055207619839883],[@bibr47-2055207619839883],[@bibr48-2055207619839883]^

A 'strong' data collection method for the main PA/SB outcome was used by 14 studies; this included research-grade accelerometers (e.g. activPAL™, Actigraph™, GENEActiv™)^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883]--[@bibr40-2055207619839883],[@bibr55-2055207619839883],[@bibr56-2055207619839883],[@bibr58-2055207619839883],[@bibr61-2055207619839883],[@bibr65-2055207619839883],[@bibr66-2055207619839883]^ and commercial activity monitors with high validity and reliability for the particular measure (e.g. Fitbit® used to monitor steps),^[@bibr42-2055207619839883],[@bibr46-2055207619839883],[@bibr49-2055207619839883],[@bibr53-2055207619839883],[@bibr59-2055207619839883],[@bibr60-2055207619839883],[@bibr74-2055207619839883]^ and the International Physical Activity Questionnaire (IPAQ) with reasonable validity and reliability.^[@bibr47-2055207619839883],[@bibr48-2055207619839883],[@bibr75-2055207619839883]^ Eight studies used 'moderate' data collection tools with either acceptable validity or reliability, including smartphone-integrated accelerometers,^[@bibr43-2055207619839883][@bibr44-2055207619839883]--[@bibr45-2055207619839883],[@bibr62-2055207619839883]^ the Activity Questionnaire for Adolescents and Adults (AQuAA),^[@bibr52-2055207619839883],[@bibr76-2055207619839883]^ the Tractivity® activity monitor,^[@bibr63-2055207619839883]^ self-entered pedometer data,^[@bibr41-2055207619839883]^ and step data from the Fitbit® converted to MVPA.^[@bibr57-2055207619839883]^ Two studies used self-reported data in non-validated questionnaires,^[@bibr50-2055207619839883],[@bibr51-2055207619839883]^ and one study^[@bibr54-2055207619839883]^ used computer software and an activity monitor with unreported validity and reliability; these were therefore given a 'weak' data collection rating.

Withdrawals and dropouts were reported by the majority of studies (*n* = 24). Definitions of attrition varied between studies but it was possible to calculate attrition rates based on the number of participants failing to provide data at the final follow-up, which ranged from 0% to 74%. Only four studies^[@bibr38-2055207619839883],[@bibr66-2055207619839883],[@bibr41-2055207619839883],[@bibr56-2055207619839883]^ were rated as 'weak' in this domain due to having particularly high attrition rates of greater than 40%.

Regarding intervention integrity, most studies reported the proportion of participants receiving the allocated intervention, which was most frequently in the range of 80--100%. Approximately two-thirds of studies reported measuring consistency of delivery or use of the intervention, with outcomes such as device wear time and interaction with technology. In the majority of studies, it was judged to be possible that participants had received an unintended intervention or this could not be determined from the reports.

Data analysis methods were generally deemed appropriate. Of the 13 RCTs, 8 used intention-to-treat analysis.^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883]--[@bibr40-2055207619839883],[@bibr44-2055207619839883],[@bibr45-2055207619839883],[@bibr52-2055207619839883],[@bibr53-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883]^

BCTs {#sec13-2055207619839883}
----

Due to the relatively small number of studies and BCTs identified, it was not possible to determine which techniques were associated with intervention efficacy. In many cases it was difficult to determine intervention content and specific BCTs used from the available descriptions. The most frequently identified BCTs (or categories of BCTs) are shown in [Table 2](#table2-2055207619839883){ref-type="table"}. These included self-monitoring of the behaviour or outcome (*n* = 22, 88% of studies), provision of feedback on the behaviour or outcome (*n* = 21, 84%), goal-setting for the behaviour or outcome (*n* = 17, 68%), social comparison (*n* = 14, 56%), social support (*n* = 12, 48%), rewards and incentives contingent on progress towards or achieving the behaviour (*n* = 11, 44%), and provision of information on consequences of PA and SB to the individual or in general (*n* = 11, 44%). Prompts and cues (*n* = 9, 36%) were also a common intervention component. Action planning was identified in eight studies (32%), graded tasks were described by four studies (16%), information on where and when to perform the behaviour was given in four studies (16%), and barrier identification/problem solving was used in three studies (12%). Instruction on how to perform the behaviour, shaping, and prompting anticipated regret were each used in two studies (8%). Information about others' approval and environmental restructuring were each found in only one study (4%). Individual or team competitions, and various types of gamification (such as virtual avatars and racing around a virtual landscape) were not part of the CALO-RE taxonomy but were used in several studies with smartphone apps and websites. Of the 40 BCTs listed in the CALO-RE taxonomy, 16 were not identified in any of the coded interventions.

Prompts and cues were used more frequently in interventions for SB; these were found in 5 of 9 studies (56%) that aimed to reduce SB compared with 6 of 22 (27%) aiming to promote PA. Rewards and incentives were more frequently part of interventions targeting PA (11/22 studies, 50%) compared with 3 of 9 (33%) studies that aimed to reduce SB.

Effects of interventions {#sec14-2055207619839883}
------------------------

Statistical methods of combining the results were not considered feasible for several reasons. There was high methodological heterogeneity with a range of different study designs, outcome measures (particularly for PA) and outcome time points. Incomplete reporting of outcome data and standard deviations precluded the calculation of reliable effect sizes. Some studies reported change in PA while others reported absolute values. In addition, several studies were either uncontrolled or did not have a 'true' control group (i.e. the comparison group received an mHealth intervention), which would have resulted in an underestimation of effect sizes. The data were therefore summarised narratively and visually. A summary of the main results for each included study is shown in [Table 4](#table4-2055207619839883){ref-type="table"}. Impact on PA, SB and health and other related outcomes is reported separately.

###### 

Summary of main results.

![](10.1177_2055207619839883-table4)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                                                                                      Key findings                                                                                                                                                                                                                                                                                                                                                                                                                                                          Subgroup findings and sensitivity analyses^a^ (if applicable)                                                                                                                                                                           Feasibility and additional findings (including engagement, attrition and acceptability)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  ---------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Brakenridge et al. 2016^[@bibr37-2055207619839883]^; Brakenridge et al. 2016^[@bibr38-2055207619839883]^   No significant between-group difference in PA or SB at 3 months (although the organisational support group only showed an increase in overall standing time, +14.6 min/day, 95% CI 2.5--26.8, ***P* = 0.018**).\                                                                                                                                                                                                                                                      No significant within- or between-group findings for any health or work-related outcomes.                                                                                                                                               **↑ PA**\                                                                                                                   **0**                                                                            Sensitivity analysis: study completers were more likely to show larger and statistically significant changes in activity at 3 months (bias from dropout of healthy participants?).                                                                                                                                                                                                                                                                     Engagement: 70.5% of participants provided with the activity monitor used it in the first 12 weeks, with mean usage of 12.1±11.6 days. Use had ceased by 12 months in all intervention participants.\
                                                                                                             Significant between-group adjusted mean difference (MD) in overall daily stepping time (+20.6 min, 95% CI 3.1--38.1, ***P* = 0.021**) and number of daily steps (+846.5 steps, 95% CI 67.8--1625.2, ***P* = 0.033**) at 12 months -- favouring the intervention group.                                                                                                                                                                                                                                                                                                                                                                                                                                        **↑ SB (favoured control)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Acceptability: 41/153 (26.8%) participants reported at least one adverse event (e.g. reactions to activity monitor or accelerometer wear).\

  Finkelstein et al. 2015^[@bibr39-2055207619839883]^; Finkelstein et al. 2016^[@bibr40-2055207619839883]^   No between-group difference in MVPA (*P* = 0.0854) or steps (*P* = 0.1362) between the Fitbit only and control groups at 6 months. Cash and charity incentive groups showed higher MVPA compared with control at 6 months (cash group MD = +29 MVPA bout mins/week, 95% CI 10--47, ***P* = 0.0024**; charity group MD = +21 MVPA bout mins/week, 95% CI 2--39, ***P* = 0.0310**).\                                                                                    No evidence for improvement in health outcomes - all intervention groups showed improvement in cardiorespiratory fitness (NET-FVO~2~ max) at 6 and 12 months, but control group showed improvement at 12 months.                        **↑ PA**                                                                                                                    **0**\                                                                           Subgroup analysis by baseline activity level found some differences -- e.g. those in the cash and charity groups who were insufficiently active at baseline showed a significant increase in MVPA from baseline to 6 months (+22 mins/week, 95% CI 5--38, ***P* = 0.0096** and +17 mins/week, 95% CI 2--32, ***P* = 0.0231** respectively). For those who were sufficiently active at baseline, changes in MPVA were non-significant in both groups.   Engagement: 40% abandoned the Fitbit within 6 months, and by month 12 only around 10% of all participants in the intervention groups were still wearing the device.\
                                                                                                             At 12 months, the Fitbit and charity groups showed higher MVPA than the control (Fitbit group MD = +37 MVPA bout mins/week, 95% CI 19--56, ***P* = 0.0001**; charity group MD = +32 MVPA bout mins/week, 95% CI 12--51, ***P* = 0.0013**). The cash incentive group did not differ from the control (*P* = 0.1363). The only significant within-group increase in MVPA at 12 months was for the Fitbit only group (+16 mins/week, 95% CI 2--30, ***P* = 0.0301**).\                                                                                                                                                                                                                                                                                                                                                                       **(improved aerobic fitness in control and intervention groups)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Attrition: predictors of loss to follow-up at 12 months included gender (higher attrition in females) and ethnicity (lower attrition in Chinese). Higher adherence was seen in the cash incentive group compared with the other groups (particularly at 6 months).\
                                                                                                             The only significant between-group differences in mean daily steps were for the cash vs. control group at 6 months (+1050 steps, 95% CI 600--1490, ***P* \< 0.0001**) and 12 months (+500 steps, 95% CI 50--960, ***P* = 0.0289**).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Ganesan et al. 2016^[@bibr41-2055207619839883]^                                                            Significant increase pre- to post-intervention in mean daily steps (+3519 steps, 95% CI 3484--3553, ***P* \< 0.0001**), exercise days/week (+0.89 days, 95% CI 0.87--0.92, ***P* \< 0.0001**) and odds of exercising ≥30 min/day (1.65, 95% CI 1.61--1.68, ***P* \< 0.0001**).\                                                                                                                                                                                       Significant pre- to post-intervention reduction in weight (−1.45kg, 95% CI --1.53 to --1.38, ***P* \< 0.0001**).                                                                                                                        **↑ PA**\                                                                                                                   **↓ weight**                                                                     Subgroup analysis by gender, year cohort, geographic region and income group -- no significant differences for any of the main outcomes.\                                                                                                                                                                                                                                                                                                              
                                                                                                             Significant decrease pre- to post-intervention in mean sitting duration (−0.74 h/day, 95% CI --0.78 to --0.71, ***P* \< 0.0001**).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            **↓ SB**                                                                                                                                                                                                     Men showed greater weight loss than women (−1.63kg, 95% CI --1.72 to --1.54 compared with --0.74kg, 95% CI --0.91 to --0.57).\                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Predictors of weight loss included increase in step count, increase in exercise days and decrease in sitting duration.                                                                                                                                                                                                                                                                                                                                 

  Gilson et al. 2016^[@bibr55-2055207619839883]^;\                                                           Non-significant increase in mean proportions of work time spent physically active from baseline to post-intervention and follow-up (+1%, 7 min/day). Non-significant decrease in mean proportions of work time spent sedentary at post-intervention (−6%) and follow-up (−9%).\                                                                                                                                                                                       Significant increase in workday fruit (***P* = 0.023**) and vegetable (***P*= 0.024**) consumption by one serving/day at end of programme.                                                                                              **0 PA**\                                                                                                                   **↑ diet(fruit and vegetable intake)**                                           N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                    Engagement: 26/44 (59%) participants used the activity monitor. Use for step count monitoring remained constant but dietary logging significantly declined from baseline to study completion.\
  Gilson et al. 2017^[@bibr56-2055207619839883]^                                                             Significant *increase* in mean proportion of workday non-work time spent sedentary baseline to follow-up (***P* = 0.007**) and decrease in mean proportion of workday non-work time stationary+ baseline to post-intervention (***P* = 0.037**) and follow-up (***P* \< 0.033**).\                                                                                                                                                                                                                                                                                                                                                                                                                            **↑ SB**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Attrition: moderately high - only 19/44 (43%) participants completed the study.\
                                                                                                             65% of participants showed positive changes in PA (and at least one dietary choice) at follow-up.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             **(workday non-work time only)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Acceptability: Barriers to technology use included technical issues, data usage costs and privacy concerns. From qualitative interviews, the overall intervention was perceived as feasible, acceptable and as having positive impact on PA by drivers and depot managers. The mHealth component was perceived to have a greater impact on behaviour than financial incentives.

  Gremaud et al. 2018^[@bibr60-2055207619839883]^                                                            Relative to control (Fitbit-only group) after the start of the intervention, the smartphone app users showed an immediate increase in mean daily steps of 2183 (95% CI 992--3344). Daily active minutes similarly increased by 12.8 (95% CI 6.3--19.3). However, participants' steps declined during the study period overall.\                                                                                                                                       Not studied                                                                                                                                                                                                                             **↑ PA**\                                                                                                                   **Not studied**                                                                  Sensitivity analyses accounting for wear compliance, and excluding data collected following a bug in the app platform did not alter the significance of the findings.                                                                                                                                                                                                                                                                                  Engagement: compliance with Fitbit wear declined over time, but app users were more likely to wear the Fitbit daily than the Fitbit-only group.\
                                                                                                             The mean longest bouts of sedentary time decreased by 26.6 min (95% CI --70.9 to--17.3) in the intervention group relative to control.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        **↓ SB**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Low attrition: 144/146 (99%) participants provided follow-up data (although short-term study).\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           **(but control group received mHealth intervention)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Acceptability: participants rated the app as easy and enjoyable to use and useful for increasing PA. The main reported barrier to technology use was Fitbit battery issues (8/48, 17% of respondents).

  Jones 2016^[@bibr42-2055207619839883]^                                                                     Between-group difference in % change in mean daily steps neared significance:\                                                                                                                                                                                                                                                                                                                                                                                        No significant within- or between-group findings for BMI, sleep or any psychosocial outcomes.                                                                                                                                           **0 PA**\                                                                                                                   **0**                                                                            N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                    Engagement: participants reporting follow-up data wore the Fitbit activity monitor for a mean of 177 of 210 days (84% adherence).\
                                                                                                             IG1 (activity monitor only) = +9%IG2 (activity monitor and active desk) = -17%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               **↑ SB (favoured control)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Attrition: dropouts were similar to study completers in terms of baseline activity, weight, gender and ethnicity.
                                                                                                             CG = --15% (*P* = 0.06, favouring the activity monitor only group)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                             Significant *increase* in sedentary time in intervention groups compared with control:IG1 = +255.5 min/day, 95% CI 127.5--383.5\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                             IG2 = +353.2 min/day, 95% CI 219.1--487.3\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                             CG = 0 min/day, 95% CI --58.6 to 58.5\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                             (***P* \< 0.0001**)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Koyle 2013^[@bibr43-2055207619839883]^                                                                     The 'control' group showed a significant within-group reduction in mean weekly walking duration from week 1 to week 6 (−50.3 min, ***P* \< 0.001**). The reduction in the intervention group was non-significant (−20.8 min/week, *P* = 0.99).\                                                                                                                                                                                                                       Significant pre- to post-intervention increase in self-efficacy beliefs (walking self-efficacy scale) for both groups: Intervention 85.6±12.1 to 90.0±10.8 (***P* = 0.0003**) and control 78.3±14.7 to 87.3±11.6 (***P* = 0.0288**).\   **↑ PA**\                                                                                                                   **↑ self-efficacy**\                                                             N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                    Acceptability: Participants in both groups commented positively on their experiences of taking part and found the study motivating. Text messages were reported as helpful.Many participants felt stronger and/or reported having lost weight as a result of taking part.At the end of the trial, all but one person chose to continue using the app.
                                                                                                             After controlling for baseline activity level, the intervention group walked more minutes than the control but a significant difference was found only at week 6 (β = 38.21, ***P* = 0.03**).                                                                                                                                                                                                                                                                         Significant decrease in resting mean pulse rate for intervention group only: 70.0±11.0 to 63.2±10.2 (***P* = 0.038**).\                                                                                                                 **(but control group received mHealth intervention)**                                                                       **↓ resting pulse rate**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   No increase in likeliness to participate in other PA.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   No significant within- or between-group findings for weight, BMI or systolic BP.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Losina et al. 2017^[@bibr57-2055207619839883]^                                                             Average weekly duration of MVPA increased from 54±64 min in 2 weeks pre-intervention to 62±89 min post-intervention (statistical significance of changes not reported).\                                                                                                                                                                                                                                                                                              Not studied                                                                                                                                                                                                                             **?(statistical significance of PA changes not reported and pre-intervention measure was contaminated by use of Fitbit)**   **Not studied**                                                                  Subgroup analysis by baseline physical ability, ethnicity and obesity found some differences. Those able to walk a mile at baseline (vs. those unable, ***P* = 0.010**), African Americans (vs. all other ethnicities, ***P* = 0.016**) and non-obese participants (vs. obese, ***P* = 0.018)** met PA guidelines more consistently throughout the programme.                                                                                          Engagement: 63% of participants were classed as adherent Fitbit wearers (i.e. wearing Fitbit ≥4 days/week for ≥20 weeks). Wear declined over time (e.g. 94% adherent wearers after 1 month vs. 62% after 6 months).\
                                                                                                             86% of participants met either their weekly PA goal or CDC PA guidelines for ≥6/24 weeks. 52% met either their PA goal or CDC guidelines for ≥12/24 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Acceptability: two-thirds of participants were satisfied with the programme; 79% indicated they would participate again.

  Neil-Sztramko et al. 2017^[@bibr58-2055207619839883]^                                                      Significant increase in mean total MVPA (+110.3 min/week, ***P* \< 0.01**) and significant increase in mean daily steps (+1488.7, ***P* \< 0.01**) from baseline to post-intervention.\                                                                                                                                                                                                                                                                               Significant pre- to post-intervention reductions in weight (mean change --0.9kg, ***P* = 0.03**) and BMI (mean change --0.3kg/m^2^, ***P* = 0.04**).\                                                                                   **↑ PA**\                                                                                                                   **↓ weight and BMI**\                                                            N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                    High engagement with Fitbit: all participants reported using the Fitbit. Of the 18 who provided Fitbit data, the device was worn 94.5% of the total study period.\
                                                                                                             Significant reductions in objective mean sedentary time (−405.5 min/week, bouts ≥10 mins, ***P* = 0.02**) and self-reported mean sedentary time (−425.3 min/week, ***P* \< 0.01**) from baseline to post-intervention.                                                                                                                                                                                                                                                Significant improvements in some domains of health-related quality of life: energy/fatigue (***P* = 0.01**) and emotional wellbeing (***P* = 0.04**).\                                                                                  **↓ SB**                                                                                                                    **↑energy/fatigue and emotional wellbeing score**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Attrition: all participants completed the study.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Significant improvements in sleep disturbances (***P* = 0.04**) and day dysfunction due to sleepiness (***P* = 0.04**).                                                                                                                                                                                                                                             **↓ sleep disturbance and day dysfunction due to sleepiness**                                                                                                                                                                                                                                                                                                                                                                                                                                                                           High acceptability: 16/19 (84.2%) participants were very or somewhat satisfied with the intervention.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Demand: high demand for participation. Recruitment to time and target was exceeded.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Implementation: technical issues were common; 5 (25%) Fitbits were returned. A further two devices were lost.

  Olsen et al. 2018^[@bibr61-2055207619839883]^                                                              No significant changes in sedentary time from pre- to post-intervention:\                                                                                                                                                                                                                                                                                                                                                                                             Not studied                                                                                                                                                                                                                             **0 PA**\                                                                                                                   **Not studied**                                                                  N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                    Moderate attrition: only 30 of the 49 (61%) recruited participants provided some post-intervention data.\
                                                                                                             Mean change in accelerometer-assessed sedentary min/day +0.08 (95% CI --30 to +30).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          **0 SB**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Acceptability: overall acceptability of the intervention was high. 90% of participants were satisfied or very satisfied with the programme and 83% agreed that the tracker was a useful tool for behaviour change.
                                                                                                             Mean change in total self-reported sitting time in office --56 mins/day (95% CI --128.5 to +17.0) and when working at home +20.5 (95% CI --64.5 to 105.5).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                             No significant changes in accelerometer-assessed or self-reported PA.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Patel et al. 2018^[@bibr62-2055207619839883]^                                                              Compared with control during the intervention period, the (unadjusted) mean proportion achieving the 7000 step goal was significantly higher for the combined lottery incentive group only (0.38 vs. 0.26). The adjusted odds ratio for achieving the goal (combined vs. control) was 3.00 (95% CI 1.28--7.02, ***P* = 0.012**).\                                                                                                                                     Not studied                                                                                                                                                                                                                             **↑ PA**\                                                                                                                   **Not studied**                                                                  Sensitivity analysis: adjusting for device and missing data did not change the significance of the findings.                                                                                                                                                                                                                                                                                                                                           Low attrition: only 6% of participants did not complete the study.
                                                                                                             No significant differences were sustained at follow-up, after incentives were removed.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       **(but control group received mHealth intervention)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                             No significant between-group differences in mean daily steps (within-group changes not reported).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Patel et al. 2016^[@bibr44-2055207619839883]^                                                              No significant between-group differences in mean daily steps (within-group changes not reported).\                                                                                                                                                                                                                                                                                                                                                                    Not studied                                                                                                                                                                                                                             **↑ PA(but control group received mHealth intervention)**                                                                   **Not studied**                                                                  Sensitivity analysis: adjusting for device and different methods of accounting for missing data did not affect the significance of the findings.                                                                                                                                                                                                                                                                                                       Low attrition: only 5% of participants did not complete the study.
                                                                                                             Proportion of participant-days 7000 step goal was achieved was significantly higher for loss incentive group compared with control for the 13 week intervention period (MD = +0.16, 95% CI 0.06--0.26, ***P* = 0.001**). This effect was not sustained at follow-up after incentives were removed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Patel et al. 2016^[@bibr45-2055207619839883]^                                                              Compared with control during the intervention period, the mean proportion achieving the 7000 step goal was significantly higher for the combined incentive group only (MD = +0.17, 95% CI 0.07--0.28, ***P* \< 0.001**). The combined incentive group also had higher mean daily steps than the control at the end of the intervention period (MD = +1446 steps, 95% CI 448--2444, ***P* = 0.005**).\                                                                 Not studied                                                                                                                                                                                                                             **↑ PA**\                                                                                                                   **Not studied**                                                                  Sensitivity analysis: adjusting for device and missing data did not affect the significance of the findings.                                                                                                                                                                                                                                                                                                                                           Low attrition: only 4% of participants failed to complete the study.
                                                                                                             No significant differences were sustained at follow-up.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       **(but control group received mHealth intervention)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Poirier et al. 2016^[@bibr46-2055207619839883]^                                                            Mean daily steps pre- to post-intervention increased for the intervention group (+309 steps/day, ±1874) and decreased for the control group (−661 steps/day, ±1824). MD = 970 steps/day, ***P* \< 0.001**.\                                                                                                                                                                                                                                                           Not studied                                                                                                                                                                                                                             **↑ PA**                                                                                                                    **Not studied**                                                                  Subgroup analysis by baseline activity level:\                                                                                                                                                                                                                                                                                                                                                                                                         High engagement with intervention: Participants wore the activity monitor on 78.6% of days (33/42) on average; e-mails were opened on 21.9% of days (9.2/42); website visits occurred every 3.6 days (11.8/42).\
                                                                                                             The proportion of participants achieving an increase of 1000 steps/day was significantly greater in the intervention group (29.9%) than the control (16.4%), ***P* = 0.018**.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sedentary group ( \< 5000 steps/day): Mean change +594±1558 steps/day in intervention group vs. +47±1299 steps/day in control group, ***P* = 0.04**.\                                                                                                                                                                                                                                                                                                  130/133 (97.7%) intervention participants still wore the activity monitor, opened e-mails and/or visited the website after 6 weeks.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Low-to-somewhat active group (5000--9999 steps/day): Mean change of --110±2106 steps/day in intervention group vs. --1286±1783 steps/day in control group, ***P* = 0.004**.\                                                                                                                                                                                                                                                                           Attrition: moderately low (around 82% provided complete follow-up data) although short term study. Participants with complete outcome data were similar to those without in terms of baseline PA level, ethnicity, income and education.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sensitivity analysis: included some study non-completers -- statistically significant between-group difference in mean daily steps remained (***P* \< 0.001**).                                                                                                                                                                                                                                                                                        

  Reijonsaari et al. 2009^[@bibr47-2055207619839883]^; Reijonsaari et al. 2012^[@bibr48-2055207619839883]^   No significant within- or between-group differences in PA: 6-month between-group adjusted MD = --365 weekly MET-minutes, 95% CI --733 to 3; 12-month between-group adjusted MD = --207 weekly MET-minutes, 95% CI --531 to 116 (negative values favour control).                                                                                                                                                                                                      No significant between-group difference in productivity (adjusted MD in QQ score at 6 months = 1.3, 95% CI --2.0 to 4.7 and adjusted MD at 12 months = --1.1, 95% CI --4.9 to 2.8).\                                                    **0 PA**                                                                                                                    **↑ weight (favoured control)**\                                                 Subgroup analyses by gender, job characteristics, age, self-rated baseline PA level and sickness absence days in the past year did not modify the results.\                                                                                                                                                                                                                                                                                            Engagement: decline in engagement (use of website, communication with coaches) over time, particularly in the last 6 months.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Between-group difference for change in weight and % body fat favoured control (adjusted MD for weight change at 12 months = --0.5kg, 95% CI --1.0 to 0.0; adjusted MD for change in % body fat = --0.6%, 95% CI --1.0 to --0.2).                                                                                                                                    **↑ % body fat (favoured control)**                                              Adherence to the intervention did not mediate sickness absence (MD between adhering and non-adhering subgroups was 0.0 days, 95% CI --1.2 to 0.9).\                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sensitivity analysis: adjusting for missing data did not affect the results.                                                                                                                                                                                                                                                                                                                                                                           

  Reed et al. 2018^[@bibr63-2055207619839883]^                                                               Initial increase in MVPA but significant decline from week 2 to week 6 (i.e. post-intervention), ***P* \< 0.05**. Significant decline in daily steps from baseline to week 6 (***P* \< 0.05**).\                                                                                                                                                                                                                                                                      Within-group significant reductions in % body fat (−0.8±4.8, ***P* = 0.015**) and resting systolic BP (−2.6±8.8 mm Hg, ***P* = 0.019**).\                                                                                               **↓ PA(steps only, and no control group)**                                                                                  **↓ % body fat**\                                                                N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                    Engagement: Participants wore the activity monitor for at least 10 hours/day for 31/42 intervention days on average (overall compliance rate 74%). Wear declined over time (e.g. average of 6.0±1.9 days per week at baseline compared with 3.5±3.0 days in week 6).\
                                                                                                             There were no significant between-group differences in either MVPA (*P* = 0.292) or steps (*P* = 0.333).                                                                                                                                                                                                                                                                                                                                                              No significant within- or between-group changes in body mass, BMI or waist circumference.                                                                                                                                                                                                                                                                           **↓ systolic BP**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Low attrition: 72/75 (96%) participants completed the study.

  Rowe-Roberts et al. 2014^[@bibr49-2055207619839883]^                                                       Findings only reported descriptively. Average daily steps reported by AUSDRISK score at beginning and end of trial; 'high' baseline score participants that moved to 'low' risk at the end of the study had the highest average daily steps at the end of the study (12,294). Average overall daily steps were:\                                                                                                                                                      23% of participants reduced their AUSDRISK score over 7 months.                                                                                                                                                                         **?(pre- to post- change in PA unclear and no control group)**                                                              **↓ AUSDRISK score**                                                             Results stratified by AUSDRISK score -- device seemed more effective for those at high risk of diabetes (see left).                                                                                                                                                                                                                                                                                                                                    Engagement: overall low engagement with the activity monitor -- average monthly dropout rate was 15% and only 36% of participants were still using the device at the end of the study.\
                                                                                                             High risk group: 8588\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            High baseline diabetes risk participants showed the highest level of engagement: Mean number of months engaged with the activity monitor = 5.7 for high risk; 4.4 for medium risk; 4.2 for low risk\
                                                                                                             Medium risk group: 7836\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Acceptability: low engagement was predominantly driven by device issues, e.g. broken, lost, forgotten devices.\
                                                                                                             Low risk group: 7878                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Individual differences in preferred motivational strategies, e.g. inactive/unengaged participants preferred games whereas active/engaged participants preferred 'goal-oriented functionalities', e.g. smart reminders and normative information about appropriate PA levels.

  Simons et al. 2018^[@bibr64-2055207619839883]^; Simons et al. 2018^[@bibr65-2055207619839883]^             No significant between-group differences in any of the objective or self-reported PA outcomes at post-intervention or follow-up (PA decreased over time in the intervention and control groups).                                                                                                                                                                                                                                                                      No significant impact on any self-reported psychosocial variables.                                                                                                                                                                      **0 PA**                                                                                                                    **0 (improved knowledge of PA guidelines in control and intervention groups)**   N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                    Engagement: Decline in engagement over time, with significant reductions in Fitbit wear, viewing graphs in the app and reading notifications.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Attrition: 110/130 (85%) participants provided primary outcome data at follow-up.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Acceptability: The majority of participants rated the Fitbit and app as self-explanatory (36/51, 71%), user friendly (40/51, 78%), and interesting (34/51, 67%), but few found the tips and facts motivating (10/41, 24%), used them to be physically active (8/41, 20%) and believed they were tailored to their lifestyle (7/41, 17%).\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Barriers to technology use included technical problems and forgetting to wear or charge the Fitbit.

  Schrager et al. 2017^[@bibr50-2055207619839883]^                                                           No significant overall change in PA level. Self-reported median (IQR) days/week of ≥30 min PA:\                                                                                                                                                                                                                                                                                                                                                                       18/30 (60%) participants described a positive impact on their wellness after one month of activity monitor use.                                                                                                                         **↑ PA**\                                                                                                                   **↑ wellness (qualitative report only)**                                         Subgroup analysis by baseline activity level and device use.\                                                                                                                                                                                                                                                                                                                                                                                          Engagement: decline in engagement over time -- 67% continued to use the device after one month, but only 33% still used their device after 6 months.\
                                                                                                             Baseline 2.5 (1.9)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           **(low baseline activity level only)**                                                                                                                                                                       Significant increase in self-reported median (IQR) days/week of ≥30 min PA for the most inactive (*n* = 10):\                                                                                                                                                                                                                                                                                                                                          Acceptability: barriers to use included forgetfulness, not wanting to wear the device, boredom, beliefs it was not accurate, technical issues and fashion.
                                                                                                             1 month 2.8 (1.5)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Baseline 1.5 (0.9)\                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                             6 months 3.0 (2.0)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1 month 2.4 (1.2)\                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                             (*P* = 0.67 for change baseline to 1 month; *P* = 0.36 for change baseline to 6 months)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   6 months 2.0 (2.0)\                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                             PA monitor-measured median (IQR) days/week ≥10,000 steps or ≥30 min PA:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (***P* = 0.04** for change baseline to 1 month; ***P* = 0.04** change baseline to 6 months)\                                                                                                                                                                                                                                                                                                                                                           
                                                                                                             Baseline 2.5 (1.9)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        No significant between- or within-group differences in PA level for those who used the activity monitor for 6 months and those who discontinued use prior to the study end.                                                                                                                                                                                                                                                                            
                                                                                                             1 month 2.5 (2.7)(*P* = 0.69 for change baseline to 1 month)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Skogstad et al. 2016^[@bibr51-2055207619839883]^                                                           Significant increase in self-reported frequency of PA from baseline to follow-up (***P* = 0.001**).\                                                                                                                                                                                                                                                                                                                                                                  Significant improvement in maximal oxygen uptake (+2.8 ml/kg/min, 95% CI 1.4--4.3, ***P* = 0.00022**).\                                                                                                                                 **↑ PA**                                                                                                                    **↑ aerobic fitness**\                                                           Subgroup analysis by education. Education was an effect modifier for diastolic BP, total and LDL cholesterol:\                                                                                                                                                                                                                                                                                                                                         Attrition: Participants lost to follow-up differed from study completers -- younger, lower HDL and higher CRP (and mostly men and blue collar workers).\
                                                                                                             % exercising at baseline:37% ≤1 day/week\                                                                                                                                                                                                                                                                                                                                                                                                                             Significant reduction in total cholesterol (−0.12 mmol/L, 95% CI --0.22 to --0.01, ***P* = 0.032**) and LDL cholesterol (−0.13 mmol/L, 95% CI --0.22 to --0.04, ***P* = 0.0034**).\                                                                                                                                                                                 **↓ total cholesterol**\                                                         Only workers with low education showed a significant increase in diastolic BP (+4.4 mm Hg, 95% CI 2.03--6.86, ***P* = 0.0004**).\                                                                                                                                                                                                                                                                                                                      Acceptability: perceived impact on other outcomes -- 12 participants reported improved nutritional habits at follow-up, 3 increased quality of sleeping, 4 reduced or quit smoking and 2 reduced alcohol intake.
                                                                                                             47% 2--3 times/week\                                                                                                                                                                                                                                                                                                                                                                                                                                                  Significant *increase* in diastolic BP (+1.67 mm Hg, 95% CI 0.23--3.12, ***P* = 0.024**).\                                                                                                                                                                                                                                                                          **↓ LDL cholesterol**\                                                           Only workers with high education showed a significant decrease in total cholesterol (−0.21 mmol/L, 95% CI --0.08 to --0.34, ***P* = 0.0015**) and LDL cholesterol (−0.22 mmol/L, 95% CI --0.12 to --0.32, ***P* = 0.0001**).                                                                                                                                                                                                                           
                                                                                                             15% ≥4 times/week\                                                                                                                                                                                                                                                                                                                                                                                                                                                    Despite the significant improvements in health outcomes (aerobic fitness, total and LDL cholesterol), further analysis could not attribute these to the change in individual PA levels.                                                                                                                                                                             **↑ diastolic BP**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                             % exercising at follow-up:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                             13% ≤1 day/week\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                             58% 2--3 times/week\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                             28% ≥4 times/week\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                             Half of participants reported increased PA frequency at follow-up.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                             Mean increase in daily low intensity PA (e.g. walking):\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                             13.7±29.4 min for men\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                             13.7±17.2 min for women.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                             Mean increase in daily high intensity PA (e.g. jogging:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                             8.3±18.2 min for men\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                             8.6±14.6 min for women                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Slootmaker et al. 2009^[@bibr52-2055207619839883]^                                                         No overall significant between-group difference in sedentary time or PA (mins/week) at 3 months or 8 months follow-up.\                                                                                                                                                                                                                                                                                                                                               No overall significant intervention effect on any secondary outcomes (aerobic fitness, determinants of PA and body composition) at 3 or 8 months.                                                                                       **↓ PA**\                                                                                                                   **↑ awareness of PA level (overweight only)**\                                   Subgroup analysis by education, adherence to programme and BMI. Education was an effect modifier for PA; higher educated intervention participants showed a significant reduction in light intensity PA at 3 months compared with control: adjusted difference in mins/week, β and 95% CI = --349 (−632 to --66), ***P* = 0.02**.\                                                                                                                     Engagement: majority of participants engaged with the intervention; 73% wore the activity monitor regularly and the website was used almost once a week.\
                                                                                                             3 month between-group difference (adjusted for gender, age, education and BMI), β and 95% CI:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                **(light-intensity, highly educated only)**\                                                                                **↓ body weight (lower educated only)**                                          The proportion of participants aware of their adherence to PA recommendations increased among overweight participants in the intervention group compared with control at 3 months (adjusted OR = 16.4, 95% CI 1.3--214, ***P* = 0.02**).\                                                                                                                                                                                                              Acceptability: barriers to technology use included lack of interest and difficulty finding items on the website.74% of activity monitor users read the tailored advice, of whom 39% found it unappealing.
                                                                                                             Sedentary time: 10 (−435 to 455)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             **0 SB**                                                                                                                                                                                                     There was a reduction in body weight among the lower educated intervention participants compared with control at 3 months (adjusted difference, β = --1.6kg, 95% CI --2.8 to --0.4, ***P* = 0.01**).\                                                                                                                                                                                                                                                  
                                                                                                             Light intensity PA: --129 (−337 to 79)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Higher engagement/adherence to the programme did not result in increased PA.                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                             Moderate intensity PA: -13 (−89 to 63)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                             Vigorous intensity PA: --6 (−75 to 62)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Thorndike et al. 2014^[@bibr53-2055207619839883]^                                                          At the end of phase 1, there was no significant difference between the intervention and control groups in median daily steps overall (intervention 6369 vs. control 6063, *P* = 0.16) or mean daily steps on days the monitor was worn (intervention 7886±3622 vs. control 7600±3492, *P* = 0.63).\                                                                                                                                                                   Significant overall reduction in systolic BP from baseline to end of study: 121±15.4 mm Hg to 117±12.6 mm Hg (***P* = 0.004**).\                                                                                                        **↑ PA(team-based competition only)**                                                                                       **↓ systolic BP**\                                                               The authors compared mean daily steps during inpatient rotations with outpatient rotations during the whole study; physicians were significantly more active during outpatient rotations (difference of 648 steps, ***P* \< 0.001**).                                                                                                                                                                                                                  Engagement: compliance with wearing the activity monitor was significantly higher in phase 2 than phase 1: 77% vs. 60%, ***P* \< 0.001**.\
                                                                                                             Mean daily steps were significantly higher in phase 2 (team competition) than phase 1 (individual monitoring) for those assigned to the control group in phase 1 (7971 vs. 7567, ***P* = 0.002**) but not for those in the intervention group (7832 vs. 7739, *P* = 0.13).                                                                                                                                                                                            Significant overall increase in HDL cholesterol from baseline to end of study: 57±14.7 mg/dL to 61±15.7 mg/dL (***P* \< 0.001**).\                                                                                                                                                                                                                                  **↑ HDL cholesterol**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   No significant change in diastolic BP, weight, BMI, waist circumference, total or LDL cholesterol.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Torquati et al. 2018^[@bibr66-2055207619839883]^                                                           Significant reduction in daily MVPA from baseline to 3 months, median (IQR): 19.1 (24.6) to 13.3 (13.9) min/day (***P* = 0.01**).\                                                                                                                                                                                                                                                                                                                                    Significant increase in daily fruit and vegetable intake from baseline to 3 months (***P* = 0.04**).\                                                                                                                                   **↓ PA**\                                                                                                                   **↑ diet(fruit and vegetable intake)**\                                          Subgroup analysis with participants with complete data only did not change the significance of the findings (although MVPA increased at month 6 following an initial reduction).                                                                                                                                                                                                                                                                       Engagement: Low engagement with the smartphone app, with 68.4% using it less than once per month or never. PA goals were set infrequently, and social components were not used.\
                                                                                                             Near significant reduction in daily MVPA from 3 months to 6 months: median (IQR): 13.3 (13.9) to 12.5 (13.4) min/day (*P* = 0.07).\                                                                                                                                                                                                                                                                                                                                   Significant improvement in self-rated health from month 3 to month 6 (***P* \< 0.05**).\                                                                                                                                                **0 SB**                                                                                                                    **↑ self-rated health**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Attrition was high, with only 12/47 (26%) attending the 6 month follow-up.\
                                                                                                             Significant reduction in mean daily steps from baseline to 3 months (8496±2528 to 8136±2395, ***P* = 0.04**).\                                                                                                                                                                                                                                                                                                                                                        No significant changes in weight, BMI, waist circumference, blood pressure, PA or diet self-efficacy or social support.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Acceptability: Participants reported that changing both PA and diet at the same time was challenging. Interviews revealed low perceived usefulness of the smartphone app.\
                                                                                                             No significant changes in sedentary time from baseline to 3 months (*P* = 0.17) or from 3 months to 6 months (*P* = 0.64).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Overall reach was poor (13% of potential participants were reached and 9.4% were willing to take part).\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Implementation: Participants required more frequent contacts with researchers or a workplace champion.

  van Dantzig et al. 2013^[@bibr54-2055207619839883]^                                                        A significantly higher reduction in computer activity (mean minutes of activity, 30 min before and after receiving (virtual) text message) was observed in the intervention group compared with control:\                                                                                                                                                                                                                                                             Not studied                                                                                                                                                                                                                             **0 PA**\                                                                                                                   **Not studied**                                                                  Engagement with the intervention was explored with subgroup analysis. There was no significant impact of proportion of text messages read on computer activity (*P*\>0.10) and no significant interaction between proportion read and time (*P*\>0.10), i.e. receiving messages led to breaks but content was not important.                                                                                                                           Engagement: an average of 46% (SD = 34.6) of the total number of text messages sent were read.
                                                                                                             Intervention group reduction of 10 min vs. control group reduction of 5.9 min, ***P* \< 0.001**.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             **↓ SB**\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                             Non-significant within- or between-group change in PA (average value during 5 min interval before and after a message) (*P*-value not reported).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              **(but control group received mHealth intervention)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Yeung et al. 2017^[@bibr59-2055207619839883]^                                                              Significant increase in median daily steps from blinded to unblinded intervention period (***P* = 0.001**):\                                                                                                                                                                                                                                                                                                                                                          Not studied                                                                                                                                                                                                                             **↑ PA**                                                                                                                    **Not studied**                                                                  Subgroup analysis by occupation. Surgical residents had significantly higher steps than non-surgical residents (***P* = 0.018),** however differential impact of the intervention was unclear.\                                                                                                                                                                                                                                                        Moderate engagement with Fitbit: device wear ranged from 91% in those volunteering for the activity tracking group to 51% in those not volunteering (unblinded period). A decline in engagement was seen over the 12 weeks in the latter group only.\
                                                                                                             Median (IQR)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Participants who elected to join the activity tracking group had higher median daily steps than those who did not (7938 vs. 7442, ***P* = 0.042**), however the direction of the effect is unclear (may be due to prior increased motivation).                                                                                                                                                                                                         Attrition: high adherence with 74/86 (86%) participants completing the study.\
                                                                                                             Weeks 1--4 (blinded): 7260 (2410) steps/day\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Acceptability: The most common barrier to participation was loss of the Fitbit (7/86, 8%).
                                                                                                             Weeks 5--8 (unblinded): 8266 (3306) steps/day\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                             Significant increase in number of participants achieving an average of ≥10,000 steps/day (***P* = 0.04**):\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                             Weeks 1--4 (blinded): *n* = 9 (12%)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                             Weeks 5--8 (unblinded): *n* = 17 (23%)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IG: intervention group; CG: control/comparison group; PA: physical activity; SB: sedentary behaviour; MVPA: moderate to vigorous physical activity; MD: mean difference; BMI: body mass index; BP: blood pressure; ±: standard deviation; N/A: non-applicable; AUSDRISK: Australian Type 2 Diabetes Risk Assessment Tool; IQR: interquartile range; LDL: low-density lipoprotein; HDL: high-density lipoprotein; CRP: C-reactive protein; OR: odds ratio; CDC: Centers for Disease Control.

**↑** = significant increase in outcome **↓** = significant decrease in outcome **0** = no significant change in outcome (between-group or within-group)

**^a^**Significant *P*-values (where reported in included papers) are in **bold**

Impact on PA {#sec15-2055207619839883}
------------

A significant increase in one or more measures of PA, over time or relative to the control or comparison group, was reported by 14 of the 25 studies (56%).^[@bibr38-2055207619839883],[@bibr40-2055207619839883],[@bibr41-2055207619839883],[@bibr43-2055207619839883][@bibr44-2055207619839883][@bibr45-2055207619839883]--[@bibr46-2055207619839883],[@bibr50-2055207619839883],[@bibr51-2055207619839883],[@bibr53-2055207619839883],[@bibr58-2055207619839883][@bibr59-2055207619839883]--[@bibr60-2055207619839883],[@bibr62-2055207619839883]^ These outcomes included mean (or median) daily steps, frequency and/or duration of activity, and odds of meeting step goals. Schrager and colleagues reported a significant impact of the intervention only in participants with a low baseline activity level.^[@bibr50-2055207619839883]^ Six studies (24%) reported no significant impact on any PA outcome.^[@bibr42-2055207619839883],[@bibr48-2055207619839883],[@bibr54-2055207619839883],[@bibr56-2055207619839883],[@bibr61-2055207619839883],[@bibr65-2055207619839883]^ Three studies (12%) reported reductions in PA; two uncontrolled studies reported reductions in daily steps,^[@bibr63-2055207619839883]^ and MVPA^66^ over time, and one RCT found a reduction in light intensity PA relative to the control group, but only in a highly educated subgroup.^[@bibr52-2055207619839883]^ It was not possible to determine the impact of the intervention in two studies; in one the pre- to post- change in PA was unclear,^[@bibr49-2055207619839883]^ and another (a feasibility study) did not report the statistical significance of changes as there was no reliable baseline measure of PA.^[@bibr57-2055207619839883]^ It should be noted that five of the 14 studies that found a relative increase in PA did not have a true (i.e. non-mHealth) control group (see [Table 4](#table4-2055207619839883){ref-type="table"}); the results suggested that one or more mHealth or complementary components had contributed to this increase, including a smartphone app,^[@bibr60-2055207619839883]^ motivational text messages^[@bibr43-2055207619839883]^ and financial incentives.^[@bibr44-2055207619839883],[@bibr45-2055207619839883],[@bibr62-2055207619839883]^

Of the 10 studies rated as 'high' or 'moderate' quality, 7 (70%) reported a significant impact of the intervention on PA.^[@bibr40-2055207619839883],[@bibr43-2055207619839883],[@bibr44-2055207619839883],[@bibr46-2055207619839883],[@bibr53-2055207619839883],[@bibr60-2055207619839883],[@bibr62-2055207619839883]^ Only 4 of the 11 studies (36%) using a wearable activity monitor as a single mHealth tool reported a significant absolute or relative increase in PA, compared with 10 of the 14 studies (71%) using smartphone apps or activity monitors combined with apps. Of the 14 studies (64%) using multi-component interventions, 9 reported a significant impact on PA,^[@bibr38-2055207619839883],[@bibr40-2055207619839883],[@bibr43-2055207619839883][@bibr44-2055207619839883]--[@bibr45-2055207619839883],[@bibr51-2055207619839883],[@bibr53-2055207619839883],[@bibr58-2055207619839883],[@bibr62-2055207619839883]^ compared with five of the 11 studies (45%) that assessed standalone mHealth interventions.^[@bibr41-2055207619839883],[@bibr46-2055207619839883],[@bibr50-2055207619839883],[@bibr59-2055207619839883],[@bibr60-2055207619839883]^ There were no other discernible associations between type or length of intervention, type of workplace and impact on PA.

Significant effects on PA were reported from 1 month to 12 months after beginning the intervention, although only three studies reported a significant increase in PA at a time point of 6 months or later.^[@bibr38-2055207619839883],[@bibr40-2055207619839883],[@bibr50-2055207619839883]^ In some cases an initial increase in PA was not sustained at later follow-up.^[@bibr44-2055207619839883],[@bibr45-2055207619839883],[@bibr62-2055207619839883],[@bibr63-2055207619839883]^ In contrast, Brakenridge and colleagues reported a significant impact of the intervention at 12 months but not 3 months.^[@bibr38-2055207619839883]^

There was wide variation in effect sizes. For example, for studies reporting a significant positive impact of the intervention on mean daily step count, this ranged from a between-group difference of around 847 (95% CI 68--1625)^38^ to 2183 (95% CI 992--3344)^60^ steps per day. The large international cohort study reported the largest effect, with a mean pre--post increase of 3519 (95% CI 3484--3553) steps per day.^[@bibr41-2055207619839883]^

Impact on sedentary behaviour {#sec16-2055207619839883}
-----------------------------

Of the 10 studies reporting impact of their intervention on sedentary time, only 4 (40%) found a significant reduction; these were a short-term wearable activity monitor and text messaging intervention in the workplace;^[@bibr54-2055207619839883]^ an activity monitor and smartphone app intervention;^[@bibr60-2055207619839883]^ an activity monitor, app and behavioural counselling intervention;^[@bibr58-2055207619839883]^ and a standalone smartphone app intervention.^[@bibr41-2055207619839883]^ Van Dantzig and colleagues found a mean between-group difference in reduction in computer activity (a proxy for sedentary time) of 4.1 min, 30 min before and after receiving a persuasive text message.^[@bibr54-2055207619839883]^ Gremaud et al. reported a reduction of 26.6 min (95% CI --70.9 to --17.3) in the mean longest sedentary time in those with an activity monitor and app compared with the activity monitor only group.^[@bibr60-2055207619839883]^ Neil-Sztramko et al. found a mean reduction in both objective and self-reported weekly sedentary time of 405.5 and 425.3 min, respectively, from baseline to 12 weeks post-intervention.^[@bibr58-2055207619839883]^ Ganesan and colleagues reported a mean reduction in self-reported daily sitting duration of 0.74 h (95% CI 0.78--0.71) after 100 days of the smartphone app intervention.^[@bibr41-2055207619839883]^

Two studies using objective measures of sedentary time showed no significant impact of a smartphone app, pedometer and social media intervention,^[@bibr66-2055207619839883]^ and a multi-component programme including an activity monitor and smartphone app combined with group-based action planning and a healthy living seminar.^[@bibr61-2055207619839883]^ Another study found no impact of an activity monitor on self-reported sedentary time at either 3 or 8 months follow-up.^[@bibr52-2055207619839883]^ A further two studies using objective measures showed significantly higher daily standing time and lower daily sedentary time respectively in controls relative to the intervention group.^[@bibr38-2055207619839883],[@bibr42-2055207619839883]^ Another study using accelerometer data reported a significant increase in the mean proportion of time spent sedentary from baseline to follow-up, but only in workday non-work time (there was a slight reduction in proportion of work time spent sedentary).^[@bibr56-2055207619839883]^

Impact on other outcomes {#sec17-2055207619839883}
------------------------

Of the 25 studies, 16 (64%) assessed the impact of the mHealth intervention on secondary outcomes including health and fitness, wellbeing and determinants of PA.^[@bibr37-2055207619839883][@bibr38-2055207619839883][@bibr39-2055207619839883][@bibr40-2055207619839883][@bibr41-2055207619839883][@bibr42-2055207619839883]--[@bibr43-2055207619839883],[@bibr47-2055207619839883][@bibr48-2055207619839883][@bibr49-2055207619839883][@bibr50-2055207619839883][@bibr51-2055207619839883][@bibr52-2055207619839883]--[@bibr53-2055207619839883],[@bibr55-2055207619839883],[@bibr56-2055207619839883],[@bibr58-2055207619839883],[@bibr63-2055207619839883],[@bibr65-2055207619839883],[@bibr66-2055207619839883]^ Of these 16 studies, 11 (69%) found an improvement in at least one outcome over time or relative to the control or comparison group.^[@bibr41-2055207619839883],[@bibr43-2055207619839883],[@bibr49-2055207619839883][@bibr50-2055207619839883][@bibr51-2055207619839883][@bibr52-2055207619839883]--[@bibr53-2055207619839883],[@bibr56-2055207619839883],[@bibr58-2055207619839883],[@bibr63-2055207619839883],[@bibr66-2055207619839883]^ Significant beneficial effects included weight or BMI reduction,^[@bibr41-2055207619839883],[@bibr58-2055207619839883]^ reduced body fat percentage,^[@bibr63-2055207619839883]^ reduced systolic blood pressure,^[@bibr53-2055207619839883],[@bibr63-2055207619839883]^ reduced resting pulse rate,^[@bibr43-2055207619839883]^ reduced total and low-density lipoprotein (LDL) cholesterol and increased high-density lipoprotein (HDL) cholesterol,^[@bibr51-2055207619839883],[@bibr53-2055207619839883]^ improved 'AUSDRISK' (Australian Type 2 Diabetes Risk) score,^[@bibr49-2055207619839883]^ improved diet,^[@bibr56-2055207619839883],[@bibr66-2055207619839883]^ improved aerobic fitness,^[@bibr51-2055207619839883]^ improved self-reported health or wellness,^[@bibr50-2055207619839883],[@bibr66-2055207619839883]^ greater self-reported energy and emotional wellbeing,^[@bibr58-2055207619839883]^ reduced sleep disturbance,^[@bibr58-2055207619839883]^ and improved self-efficacy for walking.^[@bibr43-2055207619839883]^ However, the study by Skogstad and colleagues could not attribute the changes in aerobic fitness and cholesterol levels to changes in individual PA levels.^[@bibr51-2055207619839883]^

Slootmaker and colleagues reported a significant impact on secondary outcomes in subgroups only. This included increased awareness of PA level in overweight participants only (after 3 months) and reduced body weight in lower educated participants only (after 8 months).^[@bibr52-2055207619839883]^ Four studies found no impact on any secondary outcomes,^[@bibr38-2055207619839883],[@bibr40-2055207619839883],[@bibr42-2055207619839883],[@bibr65-2055207619839883]^ and one RCT found a significant between-group difference in weight loss and percentage body fat, but in favour of the control group.^[@bibr48-2055207619839883]^ Only two studies assessed work-related outcomes including work productivity and sickness absence,^[@bibr48-2055207619839883]^ and job performance, job control and work satisfaction;^[@bibr38-2055207619839883]^ there was no significant effect on these outcomes in the short or long term.

Subgroup findings {#sec18-2055207619839883}
-----------------

The most important subgroup and sensitivity findings (where applicable) for each study are reported in [Table 4](#table4-2055207619839883){ref-type="table"}. Potential effect modifiers associated with intervention effectiveness were low baseline activity level,^[@bibr40-2055207619839883],[@bibr46-2055207619839883],[@bibr50-2055207619839883]^ lower education level,^[@bibr52-2055207619839883]^ African American ethnicity,^[@bibr57-2055207619839883]^ non-obesity,^[@bibr57-2055207619839883]^ and high risk of diabetes.^[@bibr49-2055207619839883]^

Feasibility and acceptability/additional findings {#sec19-2055207619839883}
-------------------------------------------------

Three studies were designed primarily to assess feasibility of the intervention and/or trial methods, including measures of engagement, acceptability, attrition, demand (i.e. reach and recruitment) and implementation (i.e. delivery of the intervention).^[@bibr55-2055207619839883][@bibr56-2055207619839883][@bibr57-2055207619839883]--[@bibr58-2055207619839883],[@bibr66-2055207619839883]^ Many effectiveness studies also reported some of these outcomes, with engagement and attrition measured most frequently. Definitions of engagement and acceptability were variable. Engagement with interventions tended to be measured quantitatively using outcomes such as activity monitor wear time, usage time for apps, features used or proportion of text messages read. Acceptability was a broader concept incorporating both quantitative and qualitative measures such as participant satisfaction, perceived usability, perceived effectiveness and usefulness of the intervention (for PA/SB/other outcomes), preferred components, intentions to continue technology use, barriers to use/engagement, and adverse events. Only a small number of studies assessed qualitative experiences as reported by the participants as a measure of acceptability. For example, Rowe-Roberts and colleagues used focus groups to gain further insight into employee experiences of using the activity monitor,^[@bibr49-2055207619839883]^ while Gilson and colleagues interviewed drivers and depot managers to capture experiences, insights into perceived impact of the intervention and barriers to PA.^[@bibr55-2055207619839883],[@bibr56-2055207619839883]^

The main findings in relation to engagement, acceptability and attrition are summarised in [Table 4](#table4-2055207619839883){ref-type="table"}. A clear decline in technology usage and engagement over time was reported by all longer duration studies (i.e. more than 12 weeks) that assessed these outcomes. Schrager and colleagues reported that only 33% of participants used their activity monitor after 6 months,^[@bibr50-2055207619839883]^ Brakenridge and colleagues reported that activity monitor use had ceased in all participants by 12 months,^[@bibr38-2055207619839883]^ and Finkelstein and colleagues found that only around 10% of participants still wore their activity monitor after 12 months.^[@bibr40-2055207619839883]^ Common reasons for lack of engagement were broken or lost devices,^[@bibr49-2055207619839883],[@bibr59-2055207619839883]^ forgotten devices,^[@bibr49-2055207619839883],[@bibr50-2055207619839883],[@bibr65-2055207619839883]^ lack of interest or boredom,^[@bibr50-2055207619839883],[@bibr52-2055207619839883]^ beliefs the device was not accurate,^[@bibr50-2055207619839883]^ technical issues,^[@bibr50-2055207619839883],[@bibr60-2055207619839883],[@bibr65-2055207619839883]^ fashion,^[@bibr50-2055207619839883]^ privacy concerns,^[@bibr56-2055207619839883]^ data usage costs,^[@bibr56-2055207619839883]^ and usability issues such as difficulty navigating the website.^[@bibr52-2055207619839883]^

Overall, participant satisfaction was high, and employees perceived wearable activity monitor and smartphone app interventions to be an acceptable and useful method to improve PA. Of the studies aiming to reduce SB, only two included qualitative measures of acceptability.^[@bibr56-2055207619839883],[@bibr66-2055207619839883]^ In one study, the activity monitor and smartphone app were perceived by drivers and depot managers as feasible, acceptable and as having a positive impact on PA and SB.^[@bibr56-2055207619839883]^ In contrast, a study of a smartphone app for improving diet and PA (and reducing SB) in nurses found low perceived usefulness, and interviews revealed difficulties in changing more than one behaviour at a time, and the desire for a workplace champion to implement the intervention.^[@bibr66-2055207619839883]^ Additional findings in relation to acceptability included individual differences in preferred motivational strategies according to levels of activity and engagement,^[@bibr49-2055207619839883]^ and higher compliance with activity monitor wear with team-based competition as opposed to individual monitoring.^[@bibr53-2055207619839883]^ It is also important to consider adverse events associated with technology use; in one study around 27% of participants reported at least one adverse event, typically related to reactions to wearing the activity monitor or accelerometer.^[@bibr38-2055207619839883]^ Due to the relatively small number of studies reporting measures of acceptability, and the heterogeneity of interventions and outcomes, no associations between acceptability and intervention type or length or type of workplace were evident.

Attrition rates ranged from 0% to 74%. Predictors of loss to follow-up included female gender,^[@bibr40-2055207619839883]^ younger age^[@bibr51-2055207619839883]^ and ethnicity, with lower attrition in Chinese participants.^[@bibr40-2055207619839883]^

Discussion {#sec20-2055207619839883}
==========

While methodological quality of many of the included studies was weak, based on this review there is reasonable evidence that mHealth interventions in workplace settings are a potentially effective and feasible method for increasing PA. There is some evidence that they may also be effective in reducing SB. However, findings are mixed and effect sizes are small, particularly for the impact on SB and in the longer term.

A significant increase in PA, either over time or relative to the control or comparison group, was observed in 56% (14/25) of studies, and in a higher proportion of studies rated as 'high' or 'moderate' quality (7/10, 70%). The findings in relation to SB were less clear, with only 40% (4/10) of studies reporting a significant reduction in sedentary time, and a further three studies reporting relative increases in certain measures of sedentary time. It may be that reducing sedentary time at work leads to corresponding increases in time spent sedentary outside of work; this demonstrates the importance of holistic interventions that take both work and non-work contexts into account.^[@bibr56-2055207619839883]^

It is important to assess feasibility in addition to effectiveness of complex interventions such as mHealth.^[@bibr77-2055207619839883],[@bibr78-2055207619839883]^ Many studies included measures of engagement with the intervention, and the vast majority showed a decline in engagement over time. It is not yet clear whether this disengagement from the technology is detrimental to behaviour change or if sustained behaviour change can be achieved without continued used of the mHealth tool. Future studies could draw comparisons with, and learn from, eHealth interventions to reduce SB and increase PA in the workplace, such as the studies by Mainsbridge et al. (2014),^79^ Pedersen et al. (2014)^80^ and Irvine et al. (2011).^[@bibr81-2055207619839883]^ Only a small number of studies included qualitative measures of acceptability such as interviews to explore participants' experiences, mechanisms of behaviour change and reasons for the decline in engagement. Future studies should focus on these areas. There also appears to be a need for more standardised definitions, assessment and reporting of engagement and acceptability in the field of mHealth.^[@bibr26-2055207619839883]^

The findings generally concur with the existing evidence for potential effectiveness and acceptability, most prominent in the short term, reported in reviews of mHealth interventions for PA and SB in non-workplace contexts.^[@bibr17-2055207619839883],[@bibr19-2055207619839883][@bibr20-2055207619839883]--[@bibr21-2055207619839883],[@bibr23-2055207619839883]^ Due to considerable heterogeneity and the small number of high quality studies, it was not possible to draw any definitive conclusions on the relative effectiveness or acceptability of different types of interventions, although there was some evidence that wearable activity monitors alone, and standalone mHealth interventions with no additional 'offline' components, were less likely to result in increased PA. Similarly, previous reviews have suggested that multi-component interventions may be more effective than standalone mHealth interventions.^[@bibr23-2055207619839883],[@bibr30-2055207619839883]^

This review is the first to focus on mHealth technology for the promotion of PA and reduction of SB in workplace interventions. A recent systematic review by Stephenson and colleagues that assessed the impact of computer-based, mobile and wearable technologies on SB suggested that the effects of workplace interventions may be more prominent than non-workplace interventions at medium-term follow-up.^[@bibr27-2055207619839883]^ While there was insufficient data to test this hypothesis in the present review, this highlights the potential importance of setting and the possibility of differential results.

There was a small amount of evidence to suggest that mHealth for PA and SB may be more effective for more sedentary employees,^[@bibr40-2055207619839883],[@bibr46-2055207619839883],[@bibr50-2055207619839883]^ and those with lower levels of education.^[@bibr52-2055207619839883]^ There may also be differential effectiveness according to health status at baseline,^[@bibr49-2055207619839883]^ BMI and ethnicity.^[@bibr57-2055207619839883]^ Future studies should aim to clarify which subgroups are likely to benefit most from workplace mHealth interventions. The acceptability and impact of mHealth for underrepresented groups such as shift workers, who experience unique barriers to PA and may have an elevated risk of cardiovascular disease,^[@bibr82-2055207619839883]^ diabetes^[@bibr83-2055207619839883]^ and obesity,^[@bibr84-2055207619839883]^ should also be explored further.

The review found some evidence for a positive impact on health and wellbeing outcomes (physiological and psychological) of mHealth interventions for PA and SB. It is recommended that future studies investigate the wider impact on health and wellbeing in addition to measures of 'organisational wellness' such as productivity, sickness absence and economic analyses, which were included as outcomes in only a small minority of studies. Most studies included in this review focused on workplaces in developed countries, with many based in academic and healthcare organisations. There will be a need for more diverse samples in a greater range of workplace settings as mHealth becomes more prevalent.

A 'weak' quality rating was assigned to a high proportion (15/25, 60%) of studies. Selection bias and lack of blinding were the weakest areas overall, although these are common issues in workplace and mHealth interventions.^[@bibr21-2055207619839883],[@bibr85-2055207619839883]^ Many studies lacked a true control group or did not include a reliable measure of baseline activity. Studies were highly heterogeneous in terms of methodology and outcomes, and some studies used data collection methods for the primary PA or SB outcome with below satisfactory validity and reliability. The mHealth tool itself may be an efficient method for data collection, for example most commercial activity monitors provide a real-time, objective, valid and reliable measure of step count.^[@bibr74-2055207619839883]^ This will be an important advance for studies that currently rely on self-reported data. There is also a need for improved reporting and consistent use of outcome measures to facilitate future synthesis of findings and meta-analyses. Combined with the relatively small number of included studies and mostly small sample sizes, these factors make it difficult to draw definitive conclusions regarding the impact of mHealth on PA and SB.

The most frequently used mHealth interventions were wearable activity monitors or trackers and/or smartphone apps. However, interventions were highly heterogeneous in terms of both mHealth and additional content, frequency, duration and mode of delivery. Similar to previous reviews of mHealth for PA and SB, the most commonly identified BCTs included self-monitoring, feedback, goal-setting and social comparison.^[@bibr16-2055207619839883],[@bibr23-2055207619839883],[@bibr27-2055207619839883]^ Several studies incorporated rewards (virtual or real) and social support in their interventions. Prompts and cues were more frequently used to target SB; this BCT was also frequent in the workplace interventions reviewed by Stephenson et al., compared with non-workplace interventions.^[@bibr27-2055207619839883]^ However, descriptions of interventions and BCTs were unclear or incomplete in many cases and it was not possible to determine with confidence which specific techniques were incorporated.

Future studies should aim for more transparent reporting of intervention content and specification of embedded BCTs, to facilitate identification of the most impactful and acceptable intervention components. There may also be a need for new behaviour change taxonomies specifically for mHealth interventions, for example to include in-app competitions, various types of gamification, virtual avatars, and to distinguish between virtual and real rewards. It was also apparent that many interventions did not have a strong theoretical or evidence basis. It has been suggested that new behaviour change models and theories may be needed to account for the interactive, dynamic and adaptive nature of mHealth interventions.^[@bibr86-2055207619839883]^

Long-term impact and acceptability of mHealth technology is still unclear. There is a need for studies with longer duration of follow-up, further qualitative investigation of reasons for the substantial decline in engagement over time and subsequently how engagement may be maximised. Mixed methods studies will be particularly valuable to elucidate the feasibility and acceptability of mHealth to promote PA and reduce SB in a workplace setting, as well as determining the longer-term impact on outcomes.

Strengths and limitations {#sec21-2055207619839883}
-------------------------

Strengths of this review are that it was conducted in accordance with PRISMA guidelines,^[@bibr29-2055207619839883]^ the robust nature of the search strategy, study selection and data extraction process, and the systematic assessment of study quality using the EPHPP tool.^[@bibr31-2055207619839883]^ The review comprehensively included a range of study types, with a combination of quantitative and mixed methods studies. This enabled synthesis of findings related to acceptability and engagement in addition to intervention effectiveness. The identification of BCTs using an established taxonomy will facilitate comparison of interventions and possible future replication. The review is the first to consider studies of mHealth for PA and SB that were conducted in a workplace setting.

The main limitations are that meta-analysis could not be performed due to the relatively small number of included studies, heterogeneity of methods and outcomes and incomplete reporting. The high proportion of studies rated 'weak' for methodological quality limits confidence in the findings. Furthermore, the possibility of publication bias should be recognised.

Summary of recommendations for future research {#sec22-2055207619839883}
----------------------------------------------

According to the findings of this review, it is recommended that future studies: Use larger samples in more diverse workplace settings (outside of academia and healthcare), include underrepresented groups such as shift workers, and consider behaviour both within and outside of the workplace.Report more fully intervention components (including the identification of BCTs using established taxonomies such as CALO-RE) and outcomes.Focus on SB in addition to PA, and use objective and efficient data collection methods (including the mHealth tool itself) to capture this data.Where practicable, include a no-intervention control (experimental studies) or at least a reliable baseline measure of PA/SB (for quasi-experimental studies).Consider the wider impact on health and wellbeing, and work-related outcomes such as productivity and sickness absence.Use mixed and qualitative methods to explore short- and long-term impact, feasibility and acceptability, including participants' experiences, reasons for the decline in engagement with mHealth technology, mechanisms of behaviour change, and the relationship between engagement and intervention effectiveness.Capture data on adverse events associated with mHealth technology use.Explore further the relative impact and feasibility of standalone mHealth and multi-component interventions, including those combined with other online and offline components.Explore subgroup differences, including which interventions and components/BCTs are most acceptable and impactful, and for whom.

Conclusion {#sec23-2055207619839883}
==========

There is reasonable evidence to support the use of mHealth in the promotion of PA in workplace interventions. Despite low methodological quality, early studies have demonstrated feasibility, acceptability and potential effectiveness of mHealth based interventions in a workplace context. The longer-term impact, and the impact on SB, are less clear. There is a clear need for new high quality, mixed methods studies with better reporting of interventions and outcomes, in order to explore the reasons for decline in engagement over time and the longer-term potential of mHealth in workplace interventions for promoting PA and reducing SB.
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